A Physiologically-Motivated Model of Creatinine and Fluid Volume Dynamics in Acute Kidney Injury by Richards, Evan
A PHYSIOLOGICALLY-MOTIVATED MODEL OF 
CREATININE AND FLUID VOLUME DYNAMICS 
IN ACUTE KIDNEY INJURY
by
Evan D. Richards
Submitted to the Graduate Faculty of
the Swanson School of Engineering in partial fulfillment
of the requirements for the degree of
Master of Science
University of Pittsburgh
2018
UNIVERSITY OF PITTSBURGH
SWANSON SCHOOL OF ENGINEERING
This thesis was presented
by
Evan D. Richards
It was defended on
March 26, 2018
and approved by
Robert S. Parker, Ph.D., Professor, Department of Chemical and Petroleum Engineering
Gilles Clermont, M.D., Department of Critical Care Medicine
Jason E. Shoemaker, Prodessor, Department of Chemical and Petroleum Engineering
Thesis Advisor: Robert S. Parker, Ph.D., Professor, Department of Chemical and
Petroleum Engineering
ii
Copyright c© by Evan D. Richards
2018
iii
A PHYSIOLOGICALLY-MOTIVATED MODEL OF CREATININE AND
FLUID VOLUME DYNAMICS IN ACUTE KIDNEY INJURY
Evan D. Richards, M.S.
University of Pittsburgh, 2018
Blood serum creatinine concentration (SCr) is used as a surrogate for kidney function. In an
intensive care setting, SCr is used to estimate the extent of Acute Kidney Injury (AKI). AKI
occurs in a 67% of intensive care unit (ICU) admissions [17], and it can lead to devastating
impacts on the body including the development of interstitial and pulmonary edema, toxin
accumulation, and excess mortality [8]. Previous research shows the benefits of utilizing an
absolute scale for measuring SCr [44] and the necessity to consider the impact of systemic
volume changes [32]. The present work develops a biologically-motivated, low-order model
of volume and creatinine dynamics that further progresses the understanding of an SCr
measurement.
Fluid volume is modeled into three interacting spatial compartments representing blood,
interstitial volume, and intracellular volume. The blood compartment is further divided into
plasma and liquid contained within the hematocrit (red blood cells). The four compartment
creatinine model uses a similar structure to the fluid volume model, but combines the in-
tracellular and interstitial volumes together and re-distributes these volumes between the
muscular and non-muscular regions. The rate of creatinine generation is known to decrease
during AKI [16, 33, 45]. This understanding motivates the need for a model able to capture
the influence of changes in rate of creatinine generation on the creatinine concentrations
across the included compartments. A trajectory of creatinine generation rates is included in
this work. Simulated studies of dehydration and fluid overload across six days demonstrate
the ability of this model to capture kidney function changes in scenarios where absolute SCr
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measurement would not recognize AKI as promptly. The calculated differences are shown
in hypothetical, clinical scenarios by varying levels of kidney function at differing stages of
chronic kidney disease - none, stage 2, stage 3, and stage 4. To examine the applicability of
this model for a clinical setting, its performance is tested by studying its aptitude to fit data
collected from ten different patients at the University of Pittsburgh Medical Center (UPMC)
and portray kidney function.
Patient data fits accompanied by the simulated studies demonstrate the importance of
integrating human physiology into a low-order model that considers critical components of
volume and creatinine dynamics.
v
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1.0 INTRODUCTION
Serum creatinine (SCr) levels are used to diagnose Acute Kidney Injury (AKI). AKI is
defined as an abrupt decline in glomerular filtration rate (GFR) and it causes an upset in
both fluid volume and creatinine trafficking. Fluid maintenance is required in a significant
number of admissions to the ICU [22]. Since SCr is extracted from a changing fluid volume, it
should take into account fluid dynamics . Previous studies have shown a change in creatinine
generation rate during AKI [16, 33, 45]. Interpreting SCr measurements should incorporate
these two important dynamic factors for drawing a definitive picture of GFR. Integrating
these dynamics would also support fluid management during AKI to avoid interstitial (and
pulmonary) edema [8] and dehydration.
In 2004, the first consensus definition of AKI was put forward by the “Acute Dialysis
Qualitative Initiative” (ADQI) group and the classification was called RIFLE (Risk, Injury,
Failure, Loss of kidney function, and End-stage kidney disease) [1]. The ADQI group sought
to define AKI using the % increase of SCr from standard, baseline levels and the rate of urine
output over varying time intervals [1]. Another AKI classification system was established
in May of 2007 by the Acute Kidney Injury Network (AKIN) [36]. The intention of AKIN
was to categorize AKI into three, distinct stages. Similar to the RIFLE criteria, AKIN used
a % increase in SCr over baseline and urine output criteria. AKIN also set SCr thresholds
that if surpassed would indicate a degree of AKI [36]. The classifications of RIFLE and
AKIN are given in appendix A. In March of 2009, two researchers named S. Waiker and J.
Bonventre proposed an alternative definition to AKI using SCr measurements on an absolute
scale rather than % change from baseline [44]. Their justification was that % increase in
SCr is late to detect AKI for patients pre-diagnosed with Chronic Kidney Disease (CKD).
Patients with CKD have an increased baseline level of SCr and the % change in SCr is not
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as accurate of a representation of kidney function [44]. A model of volume and SCr response
during cardiac arrest was subsequently built [32] and suggests that as body fluid volumes
change, so does the concentration of creatinine in the plasma and extravascular space [32].
A novel model embodying the interactions between volume, creatinine generation rate,
and SCr trafficking is proposed herein. Using an absolute scale for SCr measurement [44], this
model draws upon human physiology by employing kinetic principles to fluid volume traffick-
ing, SCr transport, and creatinine generation rates between anatomical compartments. The
volume model seeks to replicate volume regulatory processes at hydration levels extending
from dehydration to interstitial edema. Previous studies have found strong correlations be-
tween the change in rate of urine output and AKI [23]. These findings solidify the necessity
to develop a model capturing volume dynamics in their realistic physiologies. SCr dynamics
are volume-dependent and responsive to AKI-induced changes in creatinine clearance.
Simulated studies of dehydration and fluid overload across six days demonstrate the
ability of this model to capture kidney function changes in scenarios where absolute SCr
measurement and % SCr change would not recognize AKI as promptly. The calculated
differences are shown in hypothetical, clinical scenarios by varying levels of kidney function
at differing stages of chronic kidney disease - none, stage 2, stage 3, and stage 4. To examine
the applicability of this model for a clinical setting, its performance is tested by studying
its aptitude to fit data collected from ten different patients at the University of Pittsburgh
Medical Center (UPMC) and portray kidney function. Patient data fits accompanied by the
simulated studies conclude the importance of integrating human physiology into a trivial,
low-order model that considers critical components of volume and creatinine dynamics.
1.1 KIDNEY FUNCTION AND BIOMARKER SELECTION
The kidneys are responsible for urine formation and removal of materials the body does
not require. Figure 1.1 gives an overview of kidney function by describing the process of
glomerulus filtration, reabsorption of desired materials after filtration, and urinary excretion.
The process starts by blood flowing from the afferent arteriole to the glomerular capillaries.
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The capillaries filter the blood by removing toxic waste and ions such as potassium and
chloride. Targeted solutes and water are then reabsorbed by the peritubular capillaries. The
peritubular capillaries also secrete specific materials from the blood via active transport [13].
Tubular secretion is another mechanism of the kidneys and regulates blood volume as well
as pressure to maintain and adjust the concentration of solutes in the blood [5, 14]. These
processes promote homeostasis throughout the human physiology.
3
Figure 1.1: General kidney function and description of pathways fluid and molecular traf-
ficking through the kidneys. This figure is an adaptation of the original in Guyton and Hall’s
Textbook of Medical Physiology [13].
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If the substance or liquid is filtered or secreted and not reabsorbed, it becomes a com-
ponent of the urine composition. Because of these processes, biomarker detection in urine
is not ideal for monitoring GFR. Therefore, detection of the biomarkers in the blood serum
give a more definitive account of kidney function. The optimal biomarker will be one that is
filtered by the glomerulus, not reabsorbed, not secreted, and is not significantly influenced
by other organs in the body. Continually, biomarkers are being researched and proposed to
advance the diagnosis and treatment of AKI [25, 27, 34]. These biomarkers lack specificity
to AKI diagnosis or were found to be only comparative to clinical evaluation or standard
laboratory measurements [30]. To this point, the most ideal biomarker has been found to be
creatinine measured in the blood serum. This biomarker is currently part of the definition
of AKI [1, 36] and the intent of this work is to further improve the usage of SCr and urine
output rate as indicators of AKI.
1.2 CURRENT MODELS
Mathematical models are built in an attempt to capture pieces of reality and bring expla-
nation to conjectures in a trivial sense. Previous models have been manufactured to explain
AKI and further advance its diagnosis. Sections 1.2.1 and 1.2.2 give descriptions of two
current models published and well referenced in this field of study.
1.2.1 Waikar and Bonventre Model
In 2009, Drs. Waikar and Bonventre developed two different models that would aim to
describe SCr as a biomarker for predicting AKI. The first was a one compartment model
of creatinine and the second was a two compartment model. The two compartment model
aimed to show whether multiple compartments would yield significantly different results
in SCr measurements. For the one compartment model, the volume was 42 L [44] and
constant. So, when there was a change in SCr, this meant creatinine diffused instantaneously
throughout the whole body. Figure 1.2 illustrates their first model.
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Figure 1.2: Waikar and Bonventre’s one compartment model [44].
Equation (1.1) mathematically describes this one compartment space.
dC(t)
dt
=
(G−KC(t))
V
(1.1)
In the equation above, the system volume (V) is constant at 42 L for a 70 kg patient. Here,
creatinine generation (G) and kidney filtration (K) occur in the same compartment [44]. K
changes with GFR and G is modified with the degree of CKD. During AKI, G stays constant
at its original value. These two constants govern the concentration of creatinine (C).
Figure 1.3 shows their two compartment model. This two compartment structure was
built to illustrate the metabolism of creatinine since its generation occurs in the intracellular
space (Ci) and diffuses by first-order kinetics into the extracellular regions of the human
anatomy (Ce). The volume of the intracellular and extracellular compartments are 28L and
14L, respectively [44].
Figure 1.3: Waikar and Bonventre’s two compartment model [44].
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Equations (1.2) and (1.3) describe Figure 1.3. kie is the rate of creatinine diffusion
between Ci and Ce.
dCi(t)
dt
=
G−Kie(Ci − Ce)
Vi
(1.2)
dCe(t)
dt
=
Kie(Ci − Ce)−KCe
Ve
(1.3)
Their analysis concluded a serious flaw in using percentage change in SCr from baseline
to diagnose kidney function. They made their point evident by discussing CKD, its influence
on baseline SCr, and how any given change in creatinine clearance will yield slower rises in
SCr based on the degree of CKD present. This finding drew them to the conclusion that
an absolute scale would be more beneficial at diagnosing AKI versus a percentage change.
The one compartment model performed similarly to the two compartment model. If the two
compartment structure had considered physiological details, increased differences would be
seen in their systems.
Waikar and Bonventre made a key finding in arguing the necessity for using an absolute
scale. Considering additional items influencing SCr interpretation will also significantly
impact the time until diagnosis of AKI.
1.2.2 Pickering Model
In 2013, J.W. Pickering et. al. developed a model that would demonstrate the influence
of system volume dynamics on creatinine dynamics [32]. The motivation for their model
development was improve prediction of kidney function in patients suffering from cardiac
arrest depleted volume levels [32]. Figure 1.4 is a representation of their proposed model.
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Figure 1.4: A remake of J. W. Pickering’s model of volume and creatinine dynamics [32].
The top model is of volume dynamics. The bottom system represents the mass-balance
relationship between volume and creatinine.
The top model describes volume dynamics and the other gives the mass-balance rela-
tionship between creatinine concentration and volume. The following differential equations
were developed to mathematically describe Figure 1.4.
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dV1
dt
=
dB
dt
+
dM
dt
− dI
dt
− dU
dt
− dT
dt
(1.4)
dV2e
dt
=
dT
dt
(1.5)
dC1
dt
=
kd(C2V2 − C1V1)− krC1V1 − C1 dV1dt
V1
(1.6)
dC2
dt
=
dG
dt
+ kd(C1V1 − C2V2)− C2 dV2dt
V2
(1.7)
V1 and C1 are the volume and creatinine concentration in the blood plasma compart-
ment, respectively. Likewise, V2e and C2 are the volume and creatinine concentration in the
extravascular compartment. The initial volumes used by Pickering et. al. for compartments
V1 and V2e at t = 0 were 2.8L and 8.4L, respectively for a 70 kg hypothetical patient [32].
In Equation (1.4), dB
dt
is the liquid infusion rate, dM
dt
is the metabolic fluid production, dI
dt
is insensible fluid loss, and dU
dt
is the urine production rate. The net rate of fluid exchange
between compartments V1 and V2e is governed by Equation (1.8).
dT
dt
= Cld
(
(v1 − V1,0)
V1,0
− (v2e − V2e,0)
V2e,0
)
(1.8)
Here, v1 and v2e are measurements of the expanded compartment volumes and V1,0 and V2e,0
are the initial volumes of those compartments [32]. Cld represents the rate of distribution
clearance between the two compartments and was labeled in Figure 1.4 by Pickering et. al.
[32]. This equation demonstrates that as either volume expands or contracts, dT
dt
will adjust
to proportionally distribute fluid volume between the two compartments. This equation
grants boundless increase and decrease in volume within both the vascular and extravascular
compartmental spaces. Equation (1.9) expresses the rate of creatinine distribution (kd)
between the two creatinine compartments.
kd =
G0
C0(V2,0 − V1,0) (1.9)
G0 is the initial rate of creatinine generation and V2,0 and V1,0 are the initial volumes of the
vascular and extravascular compartments [32]. Equations (1.10) through (1.14) govern the
rates of urine production and creatinine filtration. Equation (1.11) expresses the reabsorption
rate of fluid after kidney filtration. The reabsorption rate is influenced by the level of
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hydration of the patient and is given as a piecewise function. The rate of creatinine filtration
is given by Equation (1.12) and is a product of the initial rate of creatinine generation as well
as the rate of glomerular filtration (GFR) as it is subject to change over time as indicated
by Equation 1.14. Their model depicts how GFR is influenced by kidney function [32]. If
the kidneys lose 50% of their functionality, GFR decreases by 50%.
dU
dt
= GFR(t)
(100−Reabs rate)
100
(1.10)
Reabs rate =
 99.7e−0.0000109(Hydration−90)
2.81
< 100%Hydration
1.30x10−9(120−Hydration)7.71 + 85 ≥ 100%Hydration
(1.11)
kr(t) = kr0(1−∆g(GFR(t))) (1.12)
kr0 =
g0
C0V1,0
(1.13)
∆g(GFR(t)) =
GFR(0)−GFR(t)
GFR(0)
(1.14)
The model designed by Pickering et. al. accounts for more dynamics then the model
proposed by Waikar and Bonventre. Both models have enhanced the interpretation of SCr.
The model proposed within this body of work aims to build upon the understanding of SCr
by including more physiological details of volume and creatinine dynamics. This model will
concurrently include biological equations to fluently describe biological phenomena.
1.3 MODELING OF VOLUME AND CREATININE DYNAMICS
Section 1.2 identified two prominent models used to improve the diagnosis of AKI. More
foundational detail is given here that influenced the design of the model in this work.
1.3.1 Creatinine Characteristics
Creatinine is a cyclic molecule yielded by both creatine and phosphocreatine in the human
anatomy. It has both a positive and negative charge making it a zwitterion. Zwitterions
won’t interact with the surface of non aqueous proteins or antibodies in the blood. Due
to its low interaction with other materials, SCr measurements will effectively represent the
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total amount of creatinine within the blood. Zwitterions are water soluble and will diffuse
throughout all major volume compartments [6, 39].
1.3.2 Volume Dynamics
Volume dynamics throughout multiple compartments of the human body should be ac-
counted for. AKI and total fluid volume directly impact the urinary production rate. If AKI
is not detected, fluid maintenance will continue under the assumption of nominal kidney
function. If the rate of fluid input is greater than fluid output, fluid volume will begin to
accumulate. Vascular compliance has a maximum threshold at 7L. Accumulated fluid will be
pushed to the extravascular compartments as this limit is approached. Fluid accumulation
in the interstitial compartment may yield pulmonary edema if the rate of fluid input is not
decreased [13]. Dehydration will also influence SCr measurements due to a change in total
fluid volume.
A distinction is made between the blood plasma compartment and red blood cells. SCr
measurements come from only the blood plasma. The concentration of creatinine in red
blood cells is not consistently the same as blood plasma due to the slow rate of volume
and creatinine diffusion between the two compartments [13, 39]. Generated creatinine will
enter the vascular compartment. Assuming the generated creatinine enters a 5 L whole blood
volume, the rate of SCr increase during AKI will be delayed by 40% compared to a 3 L blood
plasma compartment. Because of these conditions, a distinction should be made between
the volume of blood serum and red blood cells.
The general understandings listed here drive the development of a four compartment
volume model. Accounting for volume distribution would give more reliable diagnosis from
a SCr measurement and alert the potential for interstitial edema. Human physiology will
further direct the dynamic relationships between these four compartments in chapter 2.
1.3.3 Creatinine Concentration Dynamics
Creatinine will diffuse throughout the human anatomy, but the rate is not instantaneous
[6, 39]. Due to the slower rate of diffusion between subsections and in an effort to effectively
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capture creatinine dynamics, there are three major compartments considered for designing
the creatinine model. The compartments are plasma, red blood cells, and the extravascular
region.
Creatinine is generated in muscle located in the extravascular compartment. Muscle
does not comprise the entire space so creatinine should not diffuse directly into the en-
tire extravascular region. This subdivides the extravascular compartment into two, distinct
compartments – muscular and non-muscular. Previous studies have given reason to assume
creatinine will diffuse from the muscular space to the vascular compartment proceeding gen-
eration. The interaction of the vascular and muscular compartments from a physiological
standpoint would further conclude this assumption. Creatinine generation is not constant
during AKI [16, 45] and will significantly influence creatinine dynamics as it changes. A SCr
measurement should account for the change in creatinine generation.
Chapter 2 will elaborate upon these details at greater length.
1.4 THESIS OVERVIEW
The structure of the remainder of this work will be presented in the following order. Chap-
ter 2 gives a thorough understanding of model development. Since creatinine dynamics are
highly dependent upon volume dynamics, the first section builds the volume model. The
volume model is not static and the dynamics need to be grounded physiologically. There-
fore, mathematical equations are given to key rate constants. The next section of chapter
2 captures the creatinine dynamics and is presented with similar structure to the volume
section. The final section of this chapter compares the developed model to a static system
in hypothetical, clinical scenarios. Chapter 3 focuses on the ability of the model to fit data
given by the University of Pittsburgh Medical Center (UPMC). The chapter will first dis-
cuss the motivation for fitting the model to real data. The following section will elaborate
upon the methodology followed for selecting the patients. Proceeding patient selection, the
data is then processed for fitting. Patient data fits are then given and discussed. Chapter 4
concludes the thesis with a summary and recommendations for future work.
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2.0 MODEL DEVELOPMENT AND ANALYSIS
A compartmental approach was used to develop a mass balance model of creatinine and
volume dynamics. The models assume the patient to be 70 kg. Kinetic rates link compart-
ments and are grounded in physiological ranges when possible. The intent is to mimic these
physiological responses of fluid volume and creatinine concentrations to replicate actual ef-
fects encountered in the ICU due to changes in kidney function. Section 2.1 discusses the
synthesis of the model for volume dynamics, the associated dynamic parameters, and how
the model structure and equations were selected. Section 2.2 does the same for creatinine
dynamics. Section 2.3 applies this model to a set of theoretical, clinical scenarios. The pur-
pose of these scenarios is to illustrate the ability of this model to predict AKI when absolute
SCr measurements are incapable of doing so.
2.1 VOLUME DYNAMICS
Previously, one and two compartmental models have been used to demonstrate volume
and/or creatinine dynamics between the vascular and extravascular spaces [32, 44]. However,
there are volume dynamics in the extravascular space that will influence the volume dynam-
ics of the vascular region. In order to effectively capture interstitial edema, the extravascular
compartment (Vx(t)) is divided between intracellular (Vi(t)) and interstitial (Ve(t)) spaces.
Vi(t) will account for fluid volume in all cells except red blood cells (Vrbc(t)). Blood plas-
ma/serum (Vs(t)) and Vrbc(t) comprise the vascular compartment (Vb(t)). A schematic of
this model is shown in Figure 2.1. Fluid can exit the model three different ways. Interstitial
compartment fluid loss (E) can occur, however, it is not incorporated into the theoretical
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Figure 2.1: A four-compartment model illustrating the distribution of volume in a simulated
patient.
model. Its loss will occur as a square wave in chapter 3. Fluid output via urine produc-
tion rate (kc) and unexplained, additional losses (S) occur by Vs(t). The four-compartment
structure is characterized by the following differential equations:
dVs(t)
dt
= krsVrbc(t)− ksrVs(t) + kes(Ve(t), Vb(t))Ve(t)− kse(Ve(t), Vb(t))Vs(t)
−kc(Vtot, GFRs(t))− S(Vtot(t)) + Inf(t) (2.1)
dVrbc(t)
dt
= ksrVs(t)− krsVrbc(t) (2.2)
dVe(t)
dt
= kie(Vi(t))Vi(t)− kei(Vi(t))Ve(t) + kes(Ve(t), Vb(t))Ve(t)
+kse(Ve(t), Vb(t))Vs(t) (2.3)
dVi(t)
dt
= kei(Vi(t))Ve(t)− kie(Vi(t))Vi(t) (2.4)
Compartments Vs(t) and Vrbc(t) were used in place of Vb(t) due to the diffusion of fluid
volume and creatinine across the erythrocyte membrane not being instantaneous [39]. Ex-
travascular compartments are dynamic volumes that provide a source (in dehydration) or
sink (in fluid overload) for fluid in vivo entering the vascular compartment.
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2.1.1 Dynamic Volume Parameter Relationships
Here, we discuss the parameters used to describe dynamic relationships between the volume
compartments. To obey physiological constraints under dynamic conditions, some parame-
ters were defined using mathematical expressions.
Urine production rate was determined based on the daily rate of fluid intake and excretion
required to achieve volume equilibrium. This model considers the rate of fluid intake to be
2.3 L day-1. Fluid is delivered to the model by a bolus and/or continual infusion depending
on the condition of the patient. Parameter values not extracted from literature were set to
make the model match expected physiological states at equilibrium. At 100% hydration, fluid
is driven between compartments by osmotic forces. However, as volume levels shift toward
dehydration or edema, additional forces come in to play. With interstitial edema, there is
an increase in capillary hydrostatic pressure resulting from a loss of blood vessel compliance
as the vessels reach their maximum expansion [13]. Increased fluid flow to Ve(t) is also
due to an increase in the permeability of blood capillaries [13]. As fluid levels move toward
the state of dehydration, hormonal factors are activated in the renin-angiotensin-aldosterone
system (RAAS). RAAS regulates blood pressure within the body by releasing hormones
such as renin and angiotensin I. Angiotensin I is converted to Angiotensin II and causes
vasoconstriction to occur in order to maintain systemic blood pressure homeostasis. Renin
maintains increased salt concentrations within the vascular compartment to keep essential
fluid volume for blood flow [13]. As dehydration progresses, the renal system begins to
reabsorb fluid and ions after kidney filtration which causes kc and S to decrease. Maximum
and minimum rates of urine production were found in literature for a theoretical 70 kg patient
[13]. The resultant expression is given by Equation (2.5) and fit to the digitized scatter plot
in Figure 2.2. There are a total of three main contributors to the rate of urine production
- tubular reabsorption, glomerular filtration rate, and oliguria [37]. This model does not
account for oliguria. Though oliguria is considered a strong indicator of AKI and predictor
of mortality [23], its rate of occurrence in the ICU is not as common as the others [37]. The
equation for urine output rate is given, below.
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kc(GFRs(t), Vtot(t)) = 0.009 + GFRs(t)
0.833− 0.009
1 + e−kc,slope(Vtot(t)−kc,vol)
(2.5)
A study was conducted on humans in which the rate of urine production was measured
based on the level of hydration observed [19]. The given graph was digitized and the re-
sulting scatter plot was used to partly yield the equation determined for kc. GFRs(t) is a
representation of GFR performance on a scale from zero (no glomerular filtration) to one
(nominal kidney filtration). As shown in Equation (2.5), the rate of urine production is
regulated by GFRs(t) and the total volume of fluid (Vtot(t)). Figure 2.2 shows this equation
and how it captures the change in urine production rate as the level of hydration in a patient
changes. Parameters kc,vol and kc,slope were fit by minimizing the sum of squared error of the
data points shown Figure 2.2. The goodness of the fit was analyzed by calculating the sum
of squared error (SSE, eq. 2.7), the mean squared error (MSE, eq. 2.7), and the root mean
squared error (RMSE, eq. 2.8).
SSE =
n,max−1∑
n=0
(yn − f(xn))2 (2.6)
MSE =
1
N
n,max−1∑
n=0
(yn − f(xn))2 (2.7)
RMSE =
√
MSE (2.8)
The data point (n) is represented at yn, f(xn) is the predicted value for each data point,
and N is the total number of data points. Here, SSE = 0.0096 L2 h-2, MSE = 0.0002 L2 h-2,
and RMSE = 0.015 L h-1. This is a very low value for RMSE and allows for minimal error
when projecting urine output rate using Equation (2.5).
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Figure 2.2: Digitized plot of urine production rate (red) and the graphed expression for kc.
The rate of urine production at 100% fluid hydration is marked by two black, solid lines.
The proposed equation is graphed by a solid blue line.
The final form of the equation for kc is given by Equation (2.9).
kc(GFRs(t), Vtot(t)) = 0.009 + GFRs(t)
0.833− 0.009
1 + e−2.25(Vtot(t)−43.189)
(2.9)
The maximum rate of urine output is governed by the maximum rate of blood flow
through the kidneys. Previous studies have determined an approximate maximum rate of
urine production for a 70 kg individual [13]. The minimum rate of urine production is never
zero because urine is formed by two pathways - tubular secretion and kidney filtration. If
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kidney function is at 0%, tubular secretion will continue to produce urine [13]. The states of
dehydration have been defined [40] and Table 2.1 provides the type of dehydration associated
with the % total hydration and total volume associated with a 70 kg individual.
Table 2.1: States of dehydration for a 70 kg adult [40].
State of Percentage from Total Fluid Volume
Dehydration 42 L (%) (L)
Homeostasis ≤3 Vtot(t) ≥40.7
Mild to Moderate 3 - 9 38.2 ≤ Vtot(t) ≤ 40.7
Severe ≥9 Vtot(t) ≤38.2
This definition will be assumed throughout the rest of the work. As the body approaches
this state of dehydration, its rate of perfusion will decrease [13] but only to an approximate,
standard minimum.
Additional body fluid loss, such as sweat, is accounted for in Equation (2.10). Unlike
kc, S does not consider kidney function because the rate of perfusion is not influenced by it.
The equation for S is built to maintain constant fluid loss except during severe dehydration.
Assuming the body aims to maintain fluids during severe dehydration, S shuts off at Vtot(t)
≤ 38.2 L. Equation (2.10) gives the equation for S.
S(Vtot(t)) =
0.1/3
1 + e−6(Vtot(t)−38.2)
(2.10)
Both kc and S have built-in biological switches to account for total body fluid levels as
they approach maximum and minimum thresholds of fluid excretion. The biological switch
is a logistic equation. The logistic equation postulates that relative rates of growth will
decrease as they approach a limiting factor. The limiting factor for kc is the maximum rate
of blood flow through the kidneys [13]. The logistic equation is commonly used to explain
biological rates [2, 12] and is well-suited for this model.
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Blood volume (Vb(t) = Vs(t) + Vrbc(t)) has a maximum physiological value at the capac-
itance limit of the blood vessels. For a 70 kg individual the volume limit is 7 L [13]. The
model was able to achieve this by incorporating a biological switch into Equation (2.11) that
allows linear volume increases proportional to the increase of Ve(t) up to 7 L, after which
additional volume is forced into the extravascular space. The physiological constraints gov-
erning volume dynamics between Vs(t) and Ve(t) are captured by rates kse and kes. Equation
(2.11) gives the equation for kse. kes is a constant calculated to give system homeostasis at
100% hydration.
kse(Ve(t), Vb(t)) =
44
3
+
2.14Ve(t)
1 + e−5(Vb(t)−6.8)
(2.11)
The fraction 44
3
in Equation (2.11) is a product of Ve(t), Vs(t), and kes. Their respective
values are given in Table 2.2 and will be discussed later in greater detail.
The maximum increase in volume for a cell is approximately 50% beyond its size at
equilibrium [24, 29]. Vi(t) accounts for all cells outside the vascular compartment. Due to
osmotic effects, the observed volume increase in Vi(t) is further limited to 10% its value at
equilibrium. Equations for kie and kei translate the physiological constraints of Vi(t) into
functional form with a biological switch. If Vi(t) and Vb(t) are at maximum volume capacity,
fluid will only accumulate in the interstitial compartment.
kie(Vi(t)) =
5
1 + e3(Vi(t)−26)
(2.12)
kei(Vi(t)) =
26
11
kie (2.13)
The volume dynamics driving the diffusion of fluid between Vrbc(t) and Vs(t) were deter-
mined in previous studies [39]. Equation (2.14) shows this parameter and ksr was determined
to be 0.006h-1.
krs =
3
2
ksr (2.14)
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Figure 2.3 demonstrates the model’s ability to capture system homeostasis during nomi-
nal kidney function and standard fluid intake. This figure shows a 70 kg individual consuming
2.3 L of fluid per day. The individual is awake 16 hours per day. While awake, the individ-
ual will consume 0.2875 L once every 2 hours. The fluid is received by the model via bolus
addition to Vs(t).
Figure 2.3: Fluid distribution to each of the four volume compartments during standard
fluid intake, 100% hydration, and nominal kidney function. Fluid is given to Vs by bolus.
Fluid can also be given to the model via continuous infusion of fluid as would be done
in a hospital setting. During nominal kidney function and 100% hydration, the volumes will
become static. This static condition is important for demonstration of the model’s ability to
achieve equilibrium in all compartments. The values of the parameters during equilibrium
are shown in Table 2.2. Some of these values were given by literature while others were
calculated.
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Table 2.2: Rate and volume parameters for the 70 kg simulated patient at model equilibrium.
Parameter Value Units Source
ksr 0.006 h
−1 [39]
krs 0.009 h
−1 Calculated
kse 14.67 h
−1 Calculated
kes 4.00 h
−1 [13]
kei 11.82 h
−1 [13]
kie 5.00 h
−1 Calculated
Initial
Condition Value Units Source
Vs 3 L [13]
Vrbc 2 L [13]
Ve 11 L [13]
Vi 26 L [13]
The volumes given in the table are approximate values determined by previous studies
[13].
2.2 CREATININE CONCENTRATION DYNAMICS
The creatinine kinetics model is coupled to the volume kinetics model. Because creatinine
is a zwitterion it absorbs into extravascular fluid [39]. Its rate of diffusion between the
main regions of the body is less than true ions such as urea [39]. Understanding these
rates will give a clearer interpretation of SCr. The creatinine concentration model has
four compartments: plasma (Cs(t)), red blood cell (Crbc(t)), muscular (Cxm(t)) and the
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remaining extravascular space (Cxe(t)). Studies have shown that creatinine does not bind
to proteins [7, 39], and therefore all creatinine is processed by the kidneys. The nonvascular
compartments embody both Vi(t) and Ve(t) compartments as shown in Figure 2.1. The
distribution of fluid between volume compartments Cxm(t) and Cxe(t) was determined by
previous work stating the body is approximately 40% muscle in a healthy individual [21].
Creatinine levels in red blood cells are not quantified by SCr measurements, however, these
must be accounted for within the model as creatinine does distribute into red blood cells at a
given rate [39]. Therefore, creatinine concentrations are modeled via dynamic equilibration
across the erythrocyte membrane. Figure 2.4 shows the compartmental structure of the
creatinine concentration model. Volumes from section 2.1 associated with each compartment
are included in the figure.
Figure 2.4: A four-compartment model describing creatinine distribution in a simulated pa-
tient. The associated volumes are given adjacently to the respective creatinine compartment.
Creatinine generation (G(GFRs(t)) is a product of muscle metabolism [38, 41]. Therefore,
G(GFRs(t) occurs in Cxm(t) and not to the whole, extravascular space.
Creatinine diffuses from Cxm(t) to Cs(t) since the flow of blood through the muscular
compartment acts as a sink for creatinine that accumulates in Cxm(t). Previous models
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show the diffusion of creatinine throughout the whole extravascular region as soon as it
is generated [32]. Other research has simultaneously monitored creatinine interstitial and
serum creatinine concentrations [6]. Their works shows Cxe(t) trails Cs(t) when creatinine
levels are not held at equilibrium [6]. For this reason, Creatinine diffuses from Cxm(t) to
Cs(t) and then to compartments Cxe(t) and Crbc(t).
Mathematically, the creatinine concentration model can be represented as follows:
Vxm(t) = 0.4(Vi(t) + Ve(t)) (2.15)
Vxe(t) = 0.6(Vi(t) + Ve(t)) (2.16)
dCxe(t)
dt
=
Q(Cs(t)− Cxe(t))
Vxe(t)
− Cxe(t)
Vxe(t)
dVxe(t)
dt
(2.17)
dCxm(t)
dt
=
G(GFRs(t))
Vxm(t)
+
Q(Cs(t)− Cxm(t))
Vxm(t)
− Cxm(t)
Vxm(t)
dVxm(t)
dt
(2.18)
dCs(t)
dt
=
Q(Cxm(t) + Cxe(t)− 2Cs(t))
Vs(t)
+
R(Vrbc(t), Vs(t))(Crbc(t)− Cs(t))
Vs(t)
−kgfr(GFRs(t))Cs(t)− Cs(t)
Vs(t)
dVs(t)
dt
(2.19)
dCrbc(t)
dt
=
R(Vrbc(t), Vs(t))(Cs(t)− Crbc(t))
Vrbc(t)
(2.20)
From the volume model, extravascular volumes are given by Vxm(t) and Vxe(t). kgfr repre-
sents glomerular filtration rate. At nominal kidney function, the rate of creatinine generation
is equivalent to the rate at which creatinine is cleared. Rate constants Q and R capture the
gradient-based transport of creatinine between the plasma and extravascular, or plasma and
red blood cell, compartments, respectively. At equilibrium with nominal kidney function,
the creatinine concentrations in Cs(t), Crbc(t), and Cxe(t) are equal. Cxm(t) is greater in
creatinine concentration since creatinine generation occurs in this compartment. If the rate
constant Q was to significantly increase, Cxm(t) would approach the concentrations in the
other 3 compartments. The rates of creatinine distribution for Cxm(t) and Cxe(t) are identical
as the rate of transport of creatinine between the vascular and extravascular compartments
should be relatively equivalent [6]. Table 2.3 lists the parameter values at fluid volume and
creatinine concentration homeostasis.
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2.2.1 Dynamic Creatinine Parameter Relationships
Under dynamic conditions, parameters from Table 2.3 will have their own mathematical
relationships. Equation (2.21) was incorporated from previous research [39]. Simple diffu-
sion governs the equilibrium of creatinine between compartments Crbc(t) and Cs(t). The
functionality for R was determined experimentally to be dependent on relative compartment
volumes, water fractions, hematocrit, and overall blood volume [39].
R(Vrbc(t), Vs(t)) = A
fewVrbc(t)
( few
fpw
) Vrbc(t)
Vs(t)−Vrbc(t) + 1
(2.21)
Schneditz et. al. derived Equation (2.21) within their work [39]. They built a two
compartment model that would represent the diffusion of creatinine between erythrocytes
and blood plasma. In vitro, they recorded the movement of creatinine from red blood cells to
blood plasma and from blood plasma to red blood cells. The water fractions in their paper for
plasma (fpw) and erythrocytes (few) are 0.93 and 0.7, respectively. The rate constant A was
experimentally determined to be 3.12 h-1 +/- 0.78 h-1. Schneditz et. al. concluded the rate
of diffusion between the compartments would be dependent upon compartment volumes and
rate constants experimentally determined. Their work also showed that creatinine diffused
at a slower rate than other water soluble compounds such as urea. The final form of Equation
(2.21) is given in Equation (2.22).
R(Vrbc(t), Vs(t)) = 3.12
0.7Vrbc(t)
( 0.7
0.93
) Vrbc(t)
Vs(t)−Vrbc(t) + 1
(2.22)
The rate of glomerular filtration (kgfr(GFRs(t))) is derived from the generation rate of
creatinine (44 mg h-1), Vs(t), and Cs(t) at system homeostasis and GFRs(t) = 1. The initial
Vs(t) and Cs(t) values are given in Tables 2.2 and 2.3.
kgfr(GFRs(t)) =
44
Vs0Cs0
GFRs(t) (2.23)
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Notice kgfr(GFRs(t)) is only dependent upon changes in kidney function. This is due
to the kidney’s ability to autoregulate itself over a large range of volumes. Therefore, the
rate of glomreular filtration is constant. There are extreme conditions of blood pressure and
blood volume that could impact GFR. But, those conditions are outliers and beyond the
scope of this work.
Multiple studies have documented the significance that creatinine generation rate plays in
diagnosing AKI [16, 31, 32, 33, 45]. Previous studies have shown a decrease in G(GFRs(t))
ranging from 25 to 50% [3, 4, 31, 45]. However, the current definition of AKI does not
consider this phenomenon and current models do not include its impact as the glomerular
filtration rate varies with a patient in the ICU [33]. Dr’s Waikar and Bonventre gave rates
of creatinine generation for normal 100% kidney function and stages 2, 3, and 4 of CKD
[44]. Here, we use those reference points to build an expression for varying G(GFRs(t)) with
changes in kidney function. The values given are G(GFRs(t)) = (34.63, 38.00, 41.67, 44.00)
corresponding to scalar GFR measurements of GFRs = (0.17, 0.33, 0.67, 1.00), respectively.
Equation (2.24) is the expression to be optimized. The minimum rate of G(GFRs(t)) is 30
mg h-1 and allows for a 32% decrease in G(GFRs(t)) from 44 mg h
-1 at GFRs(t) = 1.
G(GFRs(t)) = 30.00 + Gmax
GFRs(t)
(K + GFRs(t))
(2.24)
The parameters to be fit in Equation (2.24) are Gmax and K. Gmax is the total change in
G(GFRs(t)) from GFRs(t) = 0 to GFRs(t) = ∞. The constant K is the value of GFRs(t)
marking the halfway increase increase from G(GFRs(t)) = 30 mg h
-1 to G(GFRs(t)) = 30 mg
h-1 + Gmax. Fitting the parameters in Equation (2.24) by minimizing SSE yields Equation
(2.25).
G(GFRs(t)) = 30.00 + 22.96
GFRs(t)
(0.6937 + GFRs(t))
(2.25)
The goodness of the fit was calculated and the values are SSE = 0.030 mg2 h-2, MSE =
0.008 mg2 h-2, and RMSE = 0.089 mg h-1. The RMSE indicates the equation has minimal
deviation from the provided data points. Equation (2.25) is illustrated in Figure 2.5 and
overlays the data points used for its optimization.
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Figure 2.5: Equation for G(GFRs(t)) with data points used for its fitting. The horizontal
and vertical black lines identify creatinine generation rate at GFRs = 1.
A modified form of a first order Hill equation was used to build G(GFRs(t)). The Hill
equation is continually used to express the rates of biological processes that saturate at
both high and low values [9, 35]. This model explains that human physiology will generate
creatinine even when GFRs(t)=0. Therefore, a constant is given before the Hill equation.
At nominal kidney function, G(GFRs(t)) will produce 44 mg h
-1 as shown in previous work
[44].
The rate of diffusion between the vascular and extravascular spaces (Q) was determined
by considering the Starling hypothesis. The hypothesis describes the rate of fluid movement
across capillary membranes [13]. The driving forces for fluid movement between the two
compartments are the combined differences in diffusive and osmolar flow-driven transport
[39, 40]. Creatinine’s molecular structure makes it capable of diffusing across the vascular
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boundary, but the diffusion is not immediate. A numerical constant describes the rate
of diffusion in Table 2.3. Experimental analysis found the concentrations of creatinine in
the extravascular compartment to be very similar to SCr measurements [6]. This study
also showed when creatinine levels are not static, there is a delayed response in change to
creatinine concentration in the interstitial compartment [6].
Figure 2.6 demonstrates the model’s ability to achieve equilibrium in all compartments
during system homeostasis and nominal kidney function. This is the same setup that was
used in Figure 2.3. Since the creatinine concentration model is influenced by the volume
model, Fluid bolus influence the concentrations of creatinine within each compartment.
Figure 2.6: Creatinine concentration for each of the four compartments during standard
creatinine generation and fluid intake, 100% hydration, and nominal kidney function. Fluid
is given to Vs(t) by bolus which simultaneously impacts Cs(t).
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Continuous infusion of fluid (2.3 L day-1) for a patient at 100% hydration and nominal
kidney function yields constant creatinine concentration in each compartment. Table 2.3
gives the numerical values for all parameters at system homeostasis.
Table 2.3: Creatinine model parameter set assuming a 70 kg simulated patient at volume
and creatinine mass equilibrium.
Parameter Value Units Source
Q 5.00 L · h−1 [13]
R 2.91 L · h−1 [39]
G 44 mg · h−1 [44]
kgfr 1.83 h
−1 Calculated
Initial
Condition Value Units Source
Cs 8 mg · L−1 [44]
Crbc 8 mg · L−1 [6]
Cxe 8 mg · L−1 [44]
Cxm 12.4 mg · L−1 Calculated
2.3 ANALYSIS OF RESULTANT SYSTEM DYNAMICS
In Figures 2.3 and 2.6, fluid was delivered to the model via bolus. In an ICU setting, fluid
may be infused intravenously as well as consumed orally. In this section, intravenous fluid
delivery is used for hypothetical, clinical scenarios and a 24 hour creatinine analysis.
Here we give 16 hypothetical, clinical scenarios. The 16 patients are evenly distributed to
4 categories: No CKD, stage 2, stage 3, and stage 4 CKD. Each hypothetical patient starts
with nominal kidney function and standard fluid intake (2.3 L day-1) for the first day. After
day 1, all patients stop fluid intake for 2 days. As a result of no fluid intake, that patients are
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taken to the ICU for immediate treatment / care. Each patient is instantaneously given fluid
intravenously for a whole day (24 h) at a rate of 0.5 L h-1 and their biomarkers are analyzed
(t = 72 h). The patients return to the regular fluid infusion rate of 2.3 L day-1 proceeding
the initial fluid treatment. During fluid resuscitation (t = 80 h), patients 2 through 4 lose
varying levels of kidney function. Patient 1 maintains nominal GFR (GFRs(t) = 1.0), patient
2 loses 35% (GFRs = 0.65) of their renal function, patient 3 has kidney function reduced by
70% (GFRs(t) = 0.3), and patient 4 has complete renal failure (GFRs(t) = 0.0). GFRs(t)
remains at this level for the duration of the simulation.
Figure 2.7 shows the total fluid volume of the patient in each of the four scenarios of no
CKD. At 100% kidney function, the kidneys are able to maintain system homeostasis as the
surplus of fluid given to the model is quickly removed from the entire system. As kidney
function decreases for hypothetical patients two through four, we see two notable items
occurring. First, when fluid resuscitation is underway, the fluid total in the system increases
with decreased kidney function. Secondly, we see that after fluid resuscitation completes and
kidney function is decreased, the rate of volume clearance decreases and excess fluid stays
in the body for an extended period of time. The top, black, horizontal line identifies 100%
hydration for a 70 kg patient. The lower, two lines identify the volumes for moderate and
severe dehydration in a 70 kg patient, respectively [40].
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Figure 2.7: Theoretical patients (1-4) resulting volumes at 100% kidney function. Black,
horizontal lines represent 100% hydration, minor to moderate dehydration, and severe de-
hydration in descending order. Patient number is given in the upper, right-hand corner of
each subplot.
The impact of systemic fluid trafficking can be observed under the same kidney function
scenario where systemic volume management (i.e., urine production rate) is also reduced
to 0% of nominal kidney function. Over time the maximum fluid capacity of the vascular
compartment (7L) is reached, which then induces interstitial edema, as shown in Figure 2.8.
This distribution of fluids is in agreement with physiology [13]. Though a GFRs of 0 is an
extreme case, it identifies the potential hazards of delayed identification of AKI. The model
suggests the risk of edema will increase with CKD patients.
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Figure 2.8: A characterization of the vascular volume reaching its maximum capacity and
pushing all additional fluid to the extravascular compartment. This illustration maps out
the volume distributions within Vb(t) (y-axis) and Ve(t) (x-axis).
Figure 2.9 shows the distribution of fluid throughout the body’s four major compart-
ments as the state of edema is approached. It should be noted these distributions will
change with different initial volume distribution conditions, volume infusion rates, as well
as pre-existing kidney health. The vascular and intracellular compartments reach maximum
capacity and additional fluid added to the system is directed to the interstitial compartment.
The accumulation of fluid in this compartment will eventually lead to fatal scenarios such
as pulmonary edema. Figure 2.9 shows the distribution of fluid in each compartment during
the development of interstitial edema. The vascular and intracellular compartments reach
maximum volume thresholds and excess fluid is directed to Ve(t).
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Figure 2.9: Theoretical patient volume distribution during the progression of interstitial
edema due to maximum volume compliance of vascular space being reached.
Figure 2.10 shows SCr values for the first four hypothetical patients with no history of
CKD. The solid, blue line for each patient identifies SCr for the dynamic model. The dashed
line represents SCr for the dynamic model. The loss of kidney function yields an increase
in creatinine levels in the vascular, red blood cell, and extravascular compartments (Cs(t),
Crbc(t), Cxm(t), and Cxe(t)), respectively. Notable in this figure is the minimal increase in the
rate of change in SCr for patient 4 when GFRs decreases. The rate of creatinine generation
accompanied by volume dynamics is responsible for this.
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Figure 2.10: Theoretical patients SCr over the course of six days (144h). Baseline SCr is 8
mg L-1 (No CKD present). Patient number is given in the upper, right-hand corner of each
subplot.
The results in Figure 2.10 are for patients with no CKD. However, the National Institute
of Diabetes and Digestive and Kidney Disease (NIDDK) finds that 14% of the United States
population suffers from CKD [28]. It has already been shown that an absolute scale is
necessary to measure change in SCr for CKD patients [44]. However, the absolute scale has
limitations when incorporating volume dynamics and varying creatinine generation rate and
should consider these physiological variables. Patients with CKD will hold additional fluid
volume within their system and the degree of absolute change in SCr will be amplified as
fluid volume varies. This can be seen qualitatively and quantitatively in Figures E2, E4, and
2.12.
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The same scenarios are applied to patients with stages 2, 3, and 4 CKD. Baseline SCr
values for stages 2, 3, and 4 are given the values 12, 21, and 38 mg L-1, respectively [44].
CKD introduces a new complexity to the model when considering volume dynamics and
creatinine generation rate. Since GFRs influences both of these dynamics, GFRs(t) will not
be equivalent for both the dynamic and static models at identical SCr values. To yield steady
states of the dynamic model for any potential baseline SCr value, a library was developed
of 1,000 uniformly spaced GFRs,0 values from 0 to 1. The code for developing this library is
available in Appendix B. This code produced a library of baseline values for both the static
scenario as well as the dynamic. Table 2.4 gives the values of GFRs(t) for all stages of CKD.
Table 2.4: Initial GFRs Values - Dynamic and Static Model.
Stage of SCr Baseline Dynamic Static
CKD (mgL-1) Model Model
No CKD 8 1.00 1.00
Stage 2 12 0.62 0.67
Stage 3 21 0.32 0.38
Stage 4 38 0.16 0.21
The library described above was used to determine the initial creatinine concentrations
and fluid distribution for all patients with CKD. Briefly, the library considers the initial SCr
measurement to be baseline and yields the results for the system to be at equilibrium at that
condition. Appendix B shows the process for building this library.
For patients with CKD, analysis of SCr without considering the influence of other dy-
namics becomes increasingly erroneous. The dynamic model shows how multiple factors
should be considered when diagnosing a patient based on SCr measurements and further
illustrates the necessity to consider G(GFRs(t)). Figures E1 and 2.12 show the resultant
fluid levels and SCr for patients with stage 4 CKD (13 - 16). Results for patients with stages
2 and 3 CKD are in appendix E. Here, we see the difference between the static and dynamic
systems.
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Figure 2.11: Theoretical patients (13-16) resulting volumes when baseline SCr is 38 mg L-1,
indicating no potential return to 100% kidney function and nominal kc. Black, horizontal
lines represent 100% hydration, minor dehyrdation, and severe dehydration in descending
order. Initial volume distribution set by referencing the patient library for initial conditions
to give equilibrium at t=0h. Patient number is given in the upper, right-hand corner of each
subplot.
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Figure 2.12: Theoretical patients SCr over the course of six days (144h). Baseline SCr is
38 mg L-1 (Stage 4 CKD). Patient number is given in the upper, right-hand corner of each
subplot.
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For hypothetical patients 1 through 16, SCr measurements occur upon theoretical hos-
pital admittance at t = 72h and twenty four hours later at t = 96 h. Table 2.5 identifies
the differences in changes predicted by the dynamic and static model at these time points.
In patients 1, 5, 9, 10, 13, 14, and 15, the dynamic model shows SCr decreasing between
these two time points. The static model fails to detect AKI in these patients the dynamic
model successfully predicts. Patients 10, 14, and 15 have a decrease in kidney function by
at least 35%. Stage 1 AKI (AKIN definition) is a decrease in GFR by 25% [36]. Patient
15 showed a decrease in SCr by 1.1 mg L-1 with 70% reduction in kidney function. For
the same patient, The static model predicted a 14.3 mgL-1 SCr increase over the same time
period. Complete renal failure in a patient with stage 4 CKD, SCr only increased by 3.1 mg
L-1. The static model for patient 16 shows an increase in SCr of 23.6 mg L-1. In all cases,
the static model predicts too high a change in serum creatinine since it does not account
for volume dynamics and creatinine generation rate changes. This limitation of the static
model leads to under-prediction of AKI in the ICU. The dynamic model shows an increase in
SCr during dehydration. Since the static model does not account for volume dynamics, the
increase in SCr due to dehydration would have been a false positive detection of decreased
kidney function. The contrast between the dynamic and static models becomes increasingly
apparent as the stage of CKD progresses.
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Table 2.5: Results for theoretical patients (Dynamic vs. Static models). The total decrease
in kidney function at t = 80 h for each patient is given as a % in the column labeled ’% Red.
GFRs’.
No CKD, baseline SCr = 8 mgL-1
Pat. % Red. Dynamic ∆SCr Static ∆SCr Diff. in ∆SCr % Diff. ∆SCr
ID GFRs (72 - 96h) mgL
-1 (72 - 96h) mgL-1 (72 - 96h) mgL-1 (72 - 96h)
1 0% -0.8 0.0 0.8 n/a
2 35% 1.6 3.2 1.6 50.3
3 70% 4.9 9.7 4.8 49.6
4 100% 10.5 23.6 13.1 55.6
Stage 2 CKD, baseline SCr = 12 mgL-1
5 0% -1.4 0.0 1.4 n/a
6 35% 0.9 4.1 3.2 77.8
7 70% 4.2 11.4 7.1 62.7
8 100% 9.4 23.7 14.3 60.3
Stage 3 CKD, baseline SCr = 21 mgL-1
9 0% -4.0 0.0 4.0 n/a
10 35% -1.3 5.3 6.6 125.2
11 70% 2.5 13.2 10.7 81.3
12 100% 7.1 23.6 16.5 70.0
Stage 4 CKD, baseline SCr = 38 mgL-1
13 0% -8.5 0.0 8.5 n/a
14 35% -5.2 6.3 11.5 182.6
15 70% -1.1 14.5 15.6 107.8
16 100% 3.1 23.6 20.5 86.9
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Volume changes were as great as 27% over 24 hours in the patients listed above. A change
this significant should be accounted for within a model interpreting biomarkers collected
from the blood plasma. As the degree of renal failure increases, the agreement between the
dynamic and static models decrease. Within these 16 scenarios, disagreement in results was
found to be as significant as 182.6% (Patient 14) with a decrease in kidney function of just
35%. These results show the importance of considering the volume and creatinine dynamics
presented in this work.
Blood tests in the ICU occur approximately once every 24 hours [10, 11]. SCr may
increase, decrease, or stay constant as the baseline GFRs value changes. However, kidney
function may have not remained constant. Figure 2.13 demonstrates this and shows why
one method of detection of AKI may not be enough to determine the true state of an ICU
patient. This figure compares the results when considering creatinine generation rate and
volume dynamics versus static fluid volume and no change in creatinine generation rate.
For all cases, at the first time point, the hydration is at equilibrium and fluid is continually
infused to yield 2.3 L day-1.
The model is built using a baseline SCr value of 8 mg L-1. The points on the chart identify
the initial value of GFRs(t) and the amount of time GFRs(t) stays at this value. When t
is greater than the time designated by the point, GFRs(t) returns to nominal conditions.
Throughout the process, the rate of fluid consumption is constant at 2.3 L h-1.
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Figure 2.13: Possible GFRs(t) scenarios to yield the observed ∆SCr in a 24h window. Solid
circles represent GFRs(t) results for the dynamic model. Points labeled with “x” represent
GFRs(t) with a static model. Initial SCr measurement is 8 mg L
-1.
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Figure (2.13) highlights that a static model will under-predict the depth of kidney damage
and/or the duration of kidney injury for a given ∆SCr. This becomes increasingly apparent
as ∆SCr increases from 0.1 to 11 mg L-1. Figure (2.13) also shows that a static model predicts
too large of a range of potential GFRs(t) outcomes that a true, physiological environment
would not permit. Both models at lower ∆SCr values have a large range of outcomes for
GFRs(t). An increased rate of biomarker analysis would decrease the range of outcomes.
Urine output rate monitoring over the 24 hour window would also enhance the prediction
and/or duration of kidney injury for a patient.
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3.0 MODEL FITTING TO PATIENT DATA
This chapter examines the ability of the model to fit actual patient data provided by UPMC.
First, we describe criteria for selecting the patients to be analyzed. Pairing the data with
the model will require processing the data, setting initial conditions, and developing rules
and constraints. These items are discussed in section 3.1.4.
3.1 PATIENT SELECTION AND MODEL FITTING PROCESS
3.1.1 Motivation for Model Fitting
Up to this point, we have discussed the theoretical development and advantages of this model.
The intent of this chapter is to show the performance of the model with real patient data
over an array of ∆SCr, initial conditions, volume dynamics, and final patient outcomes. The
previous chapter showed a dynamic model can provide a more timely diagnosis of AKI. The
goal of this chapter is to demonstrate that the model can capture actual patient data from a
clinical care cohort. We follow criteria outlined in Section 3.1.2 to identify ten patients from
the UPMC database that we want to be able to capture.
3.1.2 Patient Data Selection Process
All ten patients stayed in the hospital for a range of ten to twenty days. Since the model
was developed for a theoretical patient weighing 70 kg, all patients weighed between 120
and 180 pounds. None of these patients were on medical devices other then catheters. The
first measurement of SCr was required to be greater than 0 mg L-1 and less than 30 mg
42
L-1. If the first time point was not the minimum value of SCr recorded, an extra time point
was added to the beginning of the timeframe and given the minimum SCr value for that
patient. This allows the model to set a baseline SCr value at t = 0 h. Within the given
timeframe, patients 1 - 5 survived and patients 6 - 10 did not. The outcome of patients after
their hospital stay was not considered. Both surviving patients and non-surviving were given
their own categories. The two categories were made; each contained four subcategories. The
first subcategory was comprised of patients having SCr measurements that changed by 10 to
30 mg L-1. The second subcategory consisted of patients with SCr values that changed by 30
to 50mgL-1, compartment three by 50 to 70 mg L-1 and the fourth compartment by greater
than 70 mg L-1. One patient would be randomly selected for each subcategory except for
subcategory four. This subcategory contained two patients. The selection criteria had no
preference to the patient’s baseline SCr value. Figure (3.1) gives the distribution of the 10
patients.
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Figure 3.1: UPMC patient category distribution. Subcategories are given for the surviving
patients. The same subcategories are used for mortality patients.
3.1.3 Tools Utilized
For patient data processing, optimization, and graphing the following programs for Python
v3.4 were utilized: pyomo [15], pandas [26], numpy [42], and matplotlib [18]. For patient data
filtration and selection, MySQL Workbench was used along with numpy, mysql.connector,
and datetime from Python v3.4.
3.1.4 Data Processing, Constraints, and Other Critical Factors for Optimiza-
tion
Data of interest for each patient was fluid administered or consumed, fluid exiting via the
urinary tract (kc) or interstitial compartment, and measured serum creatinine values.
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3.1.5 Fluid Input
There are seven different methods of fluid administration among the ten patients. These
methods include oral intake, intravenous therapy (IV), continuous infusion, feeding tube
intake, blood products/colloids, operating room intake, enteral intake. Oral intake is the
delivery of fluid by way of oral consumption. IV is given by direct injection to the vascular
compartment over short periods of time for reasons such as drug delivery. Continuous infu-
sion is also given directly to the blood and is the controlled administration of fluid over an
extended period of time. Blood products are components of blood such as red blood cells,
platelets, fresh frozen plasma, and cryoprecipitate [20]. Since the blood product isn’t spe-
cific whether it is red blood cells or plasma, the assumption is made that all blood product
components are directed to the plasma. Colloids refer to plasma substitutes [20]. Operating
room intake is fluid input during operations. Enteral intake is nutrition delivered by way of
a feeding tube.
The medical record indicates times (tn, fluid) and total volumes of n individual fluid inputs.
The fluid is cumulatively administered from tn-1, fluid to tn, fluid at a constant rate that sums
to the total volume given. This method of fluid input can be described as a rectangular
wave. The first data point in all data sets is a SCr measurement and marks the start (t = 0
h) of the patient’s clinical visit. Some patients have fluid given at the initial time point. If
the medical record indicates fluid given at t = 0 h, it is administered to the patient as Vs(0)
= 3L+Bs where Bs is the indicated volume.
Each type of fluid was individually directed to the plasma compartment. In reality the
dynamics of the different methods of fluid input may differ. Here, all fluid inputs follow the
same set of rules.
Interstitial fluid loss (E) leaves by way of a rectangular wave as well. Its method of
leaving the model follows the same rules as fluid input.
3.1.6 Initial Conditions and Constraints
The initial conditions came from both the given data and model assumptions. Baseline SCr
values were given by compartment Cs at t = 0 h. If SCr0 was 8 mg L
-1 (indicating nominal
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kidney function), the total volume of the model (Vtot(t)) is given by the patient library in
Appendix B +/- any given fluid administered and/or exiting at t= 0 h. If a patient has a
baseline SCr measurement of 8 mg L-1, then at t = 0 h, Vi(0) = 26 L, Ve(0) = 11 L - Be,
Vs(0) = 3 L + Bs, and Vrbc(0) = 2 L. These initial volumes vary with baseline SCr.
GFRs(t) is set to predict a single value of kidney function between adjacent SCr mea-
surements. The range of possible GFRs(t) values is set by baseline SCr. GFRs(t) can take
any value from 0 to 8 mg L-1 / SCr0 where GFRs,max = 1 represents nominal kidney function
and no CKD. The reason for the limitation on the range of GFRs,max values is patients with
CKD will not have a fully functional kidney before or after AKI. Therefore, SCr0 dictates
GFRs,max. A patient could enter the hospital with AKI, but this model assumes the minimum
value to be the level of CKD. To further limit the maximum change in GFRs(t), GFRs(t) is
allowed to vary by 0.5 units from one prediction to the next. This rule is not physiologically
fortified, but is set to further constrain GFRs(t).
The initial level of hydration for each patient is unknown when they enter the ICU. Since
urine production rate can be influenced by hydration level and kidney function (GFRs(t)),
the equation for kc requires the ability to adapt per patient. For example, if a patient was
significantly dehydrated and experiencing severe changes in GFRs(t), according to Equation
(2.9), we would expect minimal influence on urine production rate from kidney function.
Equation (3.1) gives the form of kc allowing for flexibility in the expression from one patient
to the next.
kc(GFRs(t), Vtot(t)) = kc,min + GFRs
kc,max − kc,min
1 + ekc,slope(Vtot(t)−kc,vol)
(3.1)
Likewise, Equation (2.9) says if the patient was initially in a state of edema, we would
expect significant correlation of change in GFRs(t) being equivalent to change in kc. Since
the hydration level of each patient is unknown, the model is given the ability to shift the
location of the slope connecting kc,min and kc,max. In addition, the maximum and minimum
rates of of urine production per patient are subject to deviation from literature values and
are given flexibility. As is seen in the patients later in this chapter, these rates of urine
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production can vary. Table 3.1 captures the upper bound, lower bound, and initial guess for
each of these parameters that make up kc.
Table 3.1: kc parameter ranges and initial guesses
Parameter Range Initial Guess
kc,min [0.001, 0.020] 0.009
kc,max [0.6, 1.2] 0.833
kc,slope [-3.0, -1.5] -2.25
kc,vol [25.2, 55.2] 38.0
The objective function of SCr and urine output data is minimized: The squared error
of urine output total (UOT) recorded over time versus the model’s prediction of total urine
production, the squared error of recorded SCr over time versus the model’s prediction, change
in GFRs(t) from one time point (in the overall index) to the next, change in urine production
rate from one time point (in the overall index) to the next, and change in SCr from one time
point (in the overall index) to the next. The highest priority is given to minimizing the
urine production rate and SCr values. Limiting the degrees of freedom of GFRs(t) was
important for the stability of the fitting algorithm. To evaluate the model’s fit to the data
of each patient, SSE, MSE and RMSE are calculated. To limit the degrees of freedom, the
objective function penalizes change in SCr, kc, and GFRs(t) by Equation (3.2) (when n >
0). Coefficients prior to the mathematical expressions dictate the priority of an attribute in
the objective function.
SD =
n,max−1∑
n=0
(
f(xn)− f(xn−1)
tn − tn−1
)2
, n > 0 (3.2)
The solver used for the optimization process is “Interior Point OPTimizer” (IPOPT)
[43]. IPOPT is designed for large-scale optimization by finding local solutions to continuous
systems [43]. The maximum number of iterations given for the process to reach an optimal
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solution is 1x104 and the tolerance is set to 1x10-6. The tolerance is the threshold of accept-
able change in two consecutive objective function scores and defines the end-point to the
optimization process.
3.2 RESULTS AND DISCUSSION
The results for the ten patients is presented in Figures 3.2 through 3.11. Patients 1 through
5 survived their stay in the hospital and patients 6 through 10 did not. Each of these figures
consist of nine subplots and are labeled ‘a’ through ‘i’ in alphabetical order. ‘a’ details fluid
volume distribution in the patient, ‘b’ indicates the rate of volume input into the model
(all fluid enters the model by way of the plasma compartment via rectangular waves), ‘c’
gives the total UOT in the model over time, ‘d’ gives fluid distribution only within the
blood compartments to detail what the impact is on SCr, ’e’ gives the fluid volume in the
interstitial compartment and the rate of interstitial fluid leaving the model, ‘f’ gives the total
urine output over time recorded by hospital employees and the fitted total urine output given
by kc, ‘g’ is the resultant GFRs(t) based on the fitting of SCr and kc, ‘h’ details kc and is
the derivative of subplot ‘f’ with respect to time, and ‘i’ is the fitting of SCr predicted by
the model to values from the medical record.
3.2.1 Surviving Patient Fits
In Figure 3.2, patient 1 maintained fairly stable, nominal hydration levels throughout the
309 hour hospital stay as shown by kc,vol in Table 3.3. At this state of hydration, we expect
to see changes in GFRs(t) impacting both the rate of urine output as well as SCr. Of note,
the model decreases in kc when SCr increases at t=75h and an increase in urine output rate
directly proceeding SCr recovery at t=100h. Three different types of fluid were administered
to this patient including IV, oral intake, and continual infusion. The parameters for kc
are given in Table 3.2. No fluid exited the system by way of the interstitial compartment.
SCr has a minimum value of 8 mg L-1, meaning the system is capable of 100% kidney
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recovery (GFRs(t)=1). The maximum SCr measurement for patient 1 was 20mgL
-1, yielding
a maximum ∆SCr of 12 mg L-1. GFRs(t) initiated at 20% nominal kidney function. Table
3.2 gives the SSE, MSE, and RMSE of the urine and SCr fits. Overall, the model was able
to replicate patient 1 except for the end results due to the optimization formulation. At
approximately t = 260 h, the urine output rate significantly increased and the model did
not respond to it. The SCr RMSE for patient 1 (1.32 mg L-1) is less then the average SCr
RMSE for the 5 surviving patients (1.82 mg L-1). UOT RMSE for patient 1 (0.81 L) is also
less then the average UOT RMSE (1.10 L) for the 5 surviving patients. The RMSE values
show the approximate fit for the model is fairly close to the actual actual data.
Figure 3.2: Patient 1 (surviving) data and fitted results. Time in hospital = 309 h.
Patient 2 plots are given in Figure 3.3. According to the model output, fluid levels
were low for the patient upon arrival as kc,vol was at the maximum value of 55.20 L. The
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minimum and maximum values of the kc,vol window were set to allow for a large range of
initial values. At the state of dehydration predicted by kc,vol, we expect to see changes in SCr
and GFRs not influencing kc and the following results occurred. In subplot ‘f’, at t=25h,
SCr begins to increase as the urine output rate stays relatively constant. The fluid types
given to patient 2 were IV, oral intake, continuous infusion, and blood products / colloids.
The rate of IV intake at roughly t=240h is abnormally high, but only for a brief moment.
The reason for this significant increase is unknown. Baseline SCr for this patient was 24
mgL-1, meaning the maximum value of GFRs is 0.33. The maximum SCr measurement for
patient 2 was 35mgL-1, yielding a maximum ∆SCr of 11 mgL-1. As fluids continue to be
infused into patient 2, the hydration level approaches the value given by kc,vol and the rate of
urine output then significantly increases. As stated before, the initial volume of 42 L for the
model is not indicative of 100% hydration. The hydration level of a patient entering the ICU
is unknown and therefore the model must adjust for this uncertainty. The parameter kc,vol is
set to predict the fluid level of the patient at ICU admittance. If kc,vol is greater than 43.18L
(referred to Equation (2.9)), it is indicative of a dehydrated patient. Similarly, if it is less
than 43.18L, the patient is considered to be fully hydrated. Subplot ‘c’ shows the gradual
increase of total volume as 100% hydration is achieved at approximately t=230h. For this
patient, no fluid leaves the model by way of the interstitial compartment. The constraints
given to GFRs(t) may not have been significant enough as subplots ‘g’ and ’i’ oscillate more
than what would be desired. SCr RMSE for patient 2 (0.11 mg L-1) is also abnormally low
compared to the other patients. The oscillatory motion of GFRs(t) for this patient is not
ideal. Steady increases and decreases of GFRs(t) over time would be more in line with actual
changes in kidney function. UOT RMSE was typical of other values for living patients. If a
method could be developed to increase the penalty to GFRs(t), the fit would be more more
in line with reality.
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Figure 3.3: Patient 2 (surviving) data and fitted results. Time in hospital = 307 h.
In Figure 3.4, subplots for patient 3 are given. Similar to patient 2, the value of kc,vol
indicates the patient’s fluid levels were low upon arrival to the hospital. Both, the data and
the predicted urine output total in subplot ‘f’ verify this line of thought. The rate of urine
production stays constant as GFRs(t) varies with SCr. Upon admittance to the hospital, the
patient’s SCr value increased for 108 hours from 13 mg L-1 to 76 mgL-1 for a total change of 63
mgL-1. Past 108 hours, SCr data and predicted values begin to oscillate as does GFRs with no
change to the rate of kc. Since the minimum value reported for SCr is 13mgL
-1, the maximum
achievable value of GFRs is 0.62 using the equation previously described. Five types of fluid
delivery were used on patient 3: IV, oral intake, continual infusion, blood products / colloids,
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and operation intake. When the patient initially entered the hospital, they received a large
amount of fluid by way of operational intake and IV. This increased Vtot(t) to near 100%
hydration, however, the significant fluid losses had an impact on the total volume as seen
in subplot ‘e’. Significant loss of fluid in ’e’ occurs at approximately t=140h and its impact
can be seen on the components of hematocrit measurements in subplot ‘d’. The blood serum
decreased by approximately 25% as fluids shift to achieve system homeostasis. During the
patient’s stay in the hospital, SCr gradually decreases, but never fully recovers to baseline.
SCr and UOT RMSE values for patient 3 suggest a good fit to the provided data. Patient
3 highlights that increased variance in SCr with limited change change in kc is an indicator
of dehydration.
Figure 3.4: Patient 3 (surviving) data and fitted results. Time in hospital = 392 h.
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Patient 4 optimization results are provided in Figure 3.5. This patient’s kc,vol value is the
opposite of patients 2 and 3. Here, the value is 25.8L indicating the patient’s initial state of
hydration being overly hydrated. Subplot ‘f’ hints that kc,vol could have been lower as the
urine production rate predicted by the model drops off toward the end of the analysis as the
data for urine production total suggests the uring production rate stays constant throughout
the patient’s stay in the hospital. A value below 42 L for kc,vol suggests a correlation of
SCr with kc as GFRs(t) varies over time. Here, we see an increase in SCr from 7 mgL
-1 to
95 mgL-1. A baseline value of ≤8 mgL-1 permits GFRs to choose any value between 0 and
1. The model predicts GFRs to be 0 even upon admittance to the hospital with an SCr
measurement below 8 mg L-1. At the maximum measurement of SCr at roughly t=200h,
GFRs improved from 0 to 0.2. GFRs(t) slowly improves throughout the patient’s stay in the
hospital as subplot ‘g’ shows. As the health of patient 4 improves, kc significantly increases,
releasing fluid until the system reaches homeostasis as shown in subplot ‘h’. This patient
received fluids by way of 5 different methods: IV, oral intake, continuous infusion, blood
products / colloids, and a feeding tube. In subplot ‘b’, we see a significant, brief spike in
fluid infusion via feeding tube at approximately t=140h. This event appears to be correlated
with the significant loss in interstitial fluid that occurs between the time points of 75h and
130h. Patient 4 continually lost fluid via the interstitial compartment throughout their stay
in the hospital. Patient 4 undergoes a significant change in SCr and kc, yet the model
performs effectively to mimic the data collected for both urine production and SCr. This
yielded a good understanding of the kidney’s health via GFRs(t). The poor score for SCr
RMSE can be attributed to the model’s inability to capture the SCr measurement at t =
250 h. Notice also at t = 250 h, the rate of urine production decreases. Subplot ‘c’ shows a
significant decrease in Vtot(t) partly due to interstitial fluid loss. The model was not capable
of fully capturing the volume of patient 4 past t = 250 h and this played into the poor RMSE
scores. From a qualitative viewpoint, the model fit the data well.
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Figure 3.5: Patient 4 (surviving) data and fitted results. Time in hospital = 391 h.
Figure 3.6 shows the results of the 5th patient’s optimization. Over the course of 342h,
three types of fluid were administered: IV, oral intake, and continual infusion. For the first
four days, the patient was losing fluid from the interstitial compartment at a rate of 0.1 L h-1.
During the same window of time, there is an increase in the rate of IV input and continuous
infusion. According to the model, the patient was at approximately 100% hydration upon
their admittance to the hospital. As GFRs(t) changed, changes to SCr and kc responded
accordingly and fit the given data. Likewise, the rate of urine output corresponded to changes
in GFRs and these changes fit the data. Patient 5 had a baseline SCr value of 19 mg L
-1,
meaning GFRs,max=0.42. The total change in SCr was 73 mg L
-1 and was the second largest
54
increase of the five surviving patients. RMSE for both kc and SCr in Table 3.2 indicate a
good fit to the data and a qualitative analysis would agree with that conclusion.
Figure 3.6: Patient 5 (surviving) data and fitted results. Time in hospital = 342 h.
3.2.2 Mortality Outcome Patients
Patient 6 (Figure 3.7) did not survive their stay in the hospital. Over the course of 399
hours, patient 6 received fluids by IV, oral intake, and continual infusion. kc,vol indicates a
potentially low total fluid volume throughout their stay. From t = 140 h to t = 325 h, SCr
increased by 1.8 mg L-1 day-1. During this time period, there was minimal change in urine
production rate. This complements the model’s assessment of low fluid levels. According
to subplot ‘b’, the rate of continual infusion of fluids for patient 6 was 0.075 L h-1 which is
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less then the rate of fluid intake required for the model to maintain equilibrium. Fluid levels
slowly decrease throughout the patient’s 16 days. Subplot ‘e’ shows no loss of fluid by way
of Ve(t). Studying all ’b’ subplots, the collective rate of fluid consumption for patient 6 is
significantly less then any of the other 10 patients. ∆SCr for this patient was 12 mg L-1.
Subplot ‘g’ shows a gradual decrease in kidney function over time - from 55% to roughly
35%. SCr and UOT RMSE values indicate a good fit and is comparable to the results of the
surviving patients. Minimal oscillatory motion is seen with GFRs(t) which further indicates
a good fit.
Figure 3.7: Patient 6 (fatality) data and fitted results. Time in hospital = 399 h.
Similar to patient 6, patient 7 (Figure 3.8) was in the hospital for 398 h.This patient
received fluid via six methods: IV, oral intake, continual infusion, blood products / colloids,
feeding tube, and enteral intake. kc,vol predicts this patient to have fluid levels greater than
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100% upon their arrival to the hospital. Patient 6 continually lost fluid via the interstitial
compartment which caused a decrease in fluid levels during their time in the hospital. At time
points 180 h, 210 h, 260 h, and 300 h, significant fluid was lost through Ve(t). To initially
counter these losses, IV was administered at an increased rate. At t = 260 h, significant
fluid loss in Ve(t) was countered by blood products / colloids administered at a rate of 1.15
L h-1. The total change in SCr is 27 mg L-1. The data shows a gradual increase in SCr
over time. The model does not fit SCr values well for the first 100 h which is problematic.
This may be due to GFRs(t) being zero at t = 0 h and creating a significant accumulation
of creatinine in a short amount of time. The amount of oscillation present in GFRs(t) over
time is not ideal, however, its ability to fit UOT over time was good. Likewise, SCr values
were fit well at t > 100 h. SCr and UOT RMSE values for patient 7 are 5.35 mg L-1 and
2.08 L, respectively. The RMSE for SCr was the highest value recorded for all 10 patients
and is attributed to the performance of the model over the first four days. UOT RMSE was
also exceptionally high, but relatively similar to patients 8 and 9. Underlying conditions for
patient 7 not captured by the model may have influenced the results seen here. Increasing
the limitations of GFRs(t) would also improve the fit performance.
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Figure 3.8: Patient 7 (fatality) data and fitted results. Time in hospital = 398 h.
Patient 8 was in the hospital for 470 hours (19.5 days). The results of the fit for this
patient are given in Figure 3.9. Seven methods of fluid input were utilized: IV, oral intake,
continual infusion, blood products / colloids, operation intake, feeding tube, and enteral
intake. Enteral intake was steady over the first 400 hours of their stay and then decreased.
A feeding tube was utilized after their first 130 hours in the hospital. interstitial fluid was
continually lost during their time. Highly notable losses of fluid occurred at t = 180 h, 350
h, and 400 h. Its impact on the interstitial compartment and Vtot(t) are apparent. The
urine output rate over the first 10 days in the hospital was very low and the model was not
capable of capturing it. An underlying condition in this patient is not accounted for by the
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model. The model focused on minimizing the error in SCr as a result of the poor fit to UOT.
The total change in SCr was 52 mg L-1. For patient 8, SCr and UOT RMSE values are 1.16
mg L-1 and 1.84 L. This fit could be improved upon in the future.
Figure 3.9: Patient 8 (fatality) data and fitted results. Time in hospital = 470 h.
Firgure 3.10 gives the fitted results for patient 9 during their 378 hours in the hospital.
Five different methods of fluid delivery were used for this individual: IV, oral intake, contin-
ual infusion, feeding tube, and enteral intake. After t = 240 h, the only form of fluid delivery
was oral intake. Upon admittance, significant rates of fluid delivery were administered to the
patient via IV. The interstitial compartment was losing significant amounts of fluid at the
same time. kc,vol indicated close to 100% fluid hydration at t = 0 h. The significant losses
of fluid via Ve(t) countered that hydration level. Upon hospital admission, SCr continually
increased and GFRs(t) ranged from 0.0 to 0.1 over the first 3 days. GFRs(t) slowly improved
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over time. SCr ranged from 17 mg L-1 to 92 mg L-1. The effectiveness of the model to capture
the data for patient 9 was generally good. SCr and UOT RMSE values were 5.67 mg L-1
and 1.84, respectively. But, the fairly high RMSE for SCr is due to two data points missed.
The rest of the fit to SCr was good. GFRs(t) varied more than what is desirable, however,
the total variation was less then what is seen for other patients.
Figure 3.10: Patient 9 (fatality) data and fitted results. Time in hospital = 378 h.
Over the course of 394 hours, patient 10 (Figure 3.11) received three total fluid types: IV,
oral intake, and continual infusion. The rate of continual infusion was significant increased
over the course of a day. This significant fluid increase corresponded to a significant, continual
loss of interstitial fluid from t = 75 h to t = 180 h. The range of SCr values is from 9 mg L-1
to 93 mg L-1. The model did not properly fit UOT. From t = 100 h to t > 350 h, the urine
production rate was very minimal and the model was not capable of fitting this very small
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increase. An underlying condition present in patient 10 not captured by the framework of
the model is responsible for this missed ability to capture the results. Due to this, the model
assumed severe dehydration and fit the SCr data with GFRs(t). At the same time point
that SCr data began to increase, urine production significantly decreased (nearly nothing at
all). This may infer the onset of anuria as the sharp increase in SCr would conclude highly
minimal kidney function. A model capable of capturing the development of anuria would be
capable of fitting this data set. GFRs(t) varied with SCr more than what would be desired.
Overall, this fit indicates an opportunity to further develop this model.
Figure 3.11: Patient 10 (fatality) data and fitted results. Time in hospital = 394.
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Table 3.2: Patient data fit calculations SSE, MSE, and RMSE
Patient SSE SCr MSE SCr RMSE SCr SSE UOT MSE UOT RMSE UOT
# ( mg2 L-2 ) ( mg2 L-2 ) ( mg L-1 ) ( L2 ) ( L2 ) ( L )
1 22.75 1.75 1.32 38.05 0.67 0.81
2 0.18 0.01 0.11 3.61 0.36 0.60
3 84.27 3.83 1.96 6.82 0.11 0.33
4 516.11 19.11 4.37 1279.78 9.77 3.12
5 48.74 1.87 1.36 63.62 0.41 0.64
6 3.38 0.18 0.42 8.00 0.28 0.53
7 714.43 28.57 5.35 268.87 4.34 2.08
8 29.48 1.34 1.16 384.70 3.37 1.84
9 664.02 32.20 5.67 200.17 3.39 1.84
10 56.14 2.55 1.60 93.22 1.73 1.31
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Table 3.3: Patient kc parameter fit results
Patient # kc,vol kc,min kc,max kc,slope
1 42.54 0.001 0.600 -1.5
2 55.20 0.015 0.600 -3.0
3 55.19 0.020 0.600 -3.0
4 25.82 0.02 1.200 -1.5
5 44.90 0.020 1.200 -1.5
6 50.86 0.012 0.898 -2.6
7 35.83 0.001 0.600 -3.0
8 55.19 0.001 0.600 -3.0
9 39.61 0.020 0.675 -1.5
10 55.16 0.014 0.652 -3.0
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3.2.3 Patient Fitting Conclusions
The model demonstrated the ability to capture many attributes of real patient data. The
correlation of kidney function impacting both SCr and fluid dynamics was evident in patients
at 100% fluid hydration. As expected, patients below 100% fluid hydration did not have
changes in urine production rate adjust with SCr measurements. Surviving patients had
better model fitting performance. This may be due to underlying conditions that exist with
fatality patients. Discovering some of the more prominent conditions in a population and
incorporating those conditions into this model may aid clinicians in diagnosing their patients.
Developing a more effective way to penalize GFRs(t) would also enhance the performance
of this model. Another effective way to improve this model would be to adjust the initial
volumes rather then adjusting kc,vol to capture the initial state of hydration of a patient. This
would allow for the physiologically guided development of this model to accurately capture
fluid distribution of a patient.
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4.0 SUMMARY AND FUTURE WORK
4.1 SUMMARY
In this work, we suggest the importance of a model grounded in physiological principals to
more accurately and quickly detect acute kidney injury and help avoid interstitial edema. In
Chapter 1, we discuss previously developed models and how they influenced the understand-
ing of AKI. Chapter 2 develops a model structure that captures the four main volume and
creatinine compartments within the human anatomy of a 70 kg individual. Under dynamic
conditions, rate constants connecting the compartments were given mathematical relation-
ships that were biologically correspondent. Additionally, a non-static approach to creatinine
generation and urine production rates were woven into the model. After discussing the model
development, sixteen hypothetical scenarios were drawn to give possible incidences that may
occur in the ICU. GFRs(t) outcomes were predicted with a model that considers only cre-
atinine dynamics versus a model considering volume, creatinine, and creatinine generation
dynamics. The outcomes of this study show how the dynamic model is capable of predicting
AKI in situations where a static model fails to identify kidney injury. Proceeding these sce-
narios, the static and dynamic models were projected over a 24 hour period to demonstrate
potential GFRs(t) decreases required to generate an observed ∆SCr. The results of this
study highlights that a static model under-predicts the depth of kidney damage and/or the
duration of kidney injury for a given ∆SCr.
The intent of chapter 3 is to detail the strengths and limitations of the model designed
in chapter 2. Chapter 3 fits the model to data of ten patients in the ICU at UPMC. One key
finding of this chapter is the rate of urine production proceeding kidney function increase. As
GFRs(t) increased, if the patient is hydrated, urine production rate significantly increases.
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Identifying physical indicators of kidney recovery such as this one could further aid in the
recovery process. Also, in patients that were dehydrated throughout their stay in the ICU,
urine production rate remained constant as SCr continually changed. This was the case
for patients 2, 3, 5, 6, and 9. The level of correlation between changes in SCr and urine
production rate should be used as an indicator that a patient may be in need of additional
fluids. Overall, surviving patients fit the model better than patients who did not survive.
Outlier conditions present in the non-surviving patients may not be captured by the model
which could be a factor that impacts the fits.
4.2 FUTURE WORK
There is a multitude of directions this work could take going forward. Tubular secretion
was not accounted for here and could be studied to determine if it would have significant
impact on the model. Tubular secretion works via active transport and moves creatinine from
the blood plasma to the urinary tract [13]. To verify whether or not the rate of secretion is
dynamic as GFRs(t) changes would lead to further validation of SCr as a key biomarker in the
prediction of AKI. Another direction this work could consider is the prediction of an accurate
total fluid volume at t=0 h for the model optimization. Currently, the model always initiates
at 42 L. However, not all patients are at this level of hydration. The current model seeks to
account for the state of dehydration by adjusting kc,vol, however, this negates the effectiveness
of the dynamic rates between the volumetric compartments. Hematocrit is a data point
collected that could be utilized to determine the rate of volume dynamics between Vb(t)
and Vs(t). This work studies the physiologies of a 70 kg individual. Considering weights
more prone to AKI may be beneficial. Likewise, other attributes such as age, gender, and
pre-existing conditions could further improve the usefulness of this system. Patients entering
the ICU may have issues with more organs than just the kidneys. Tying this model in with
mathematical representations of other organs and how they play off of one another could also
be insightful. The rate of creatinine generation in a dehydrated individual was not considered
in this paper and may have an impact on SCr measurements if dehydration influences it.
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Hormonal influences on volume dynamics were considered, but more research could lead to
further model development. Considering the influence of common health issues would be
another path to consider.
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APPENDIX A
RIFLE AND AKIN DEFINITIONS OF AKI
Table A1: RIFLE Classification of AKI [1] which includes designation for urinary output
and SCr. End Stage Kidney Disease is Abbreviated ESKD. Urinary output = UO.
GFR Criteria Urine Output Criteria
Risk Increase SCr x 1.5 or UO < 0.5 ml/kg/h
GFR decrease > 25% x6h
Injury Increased SCr x2 UO < 0.5 ml/kg/h
or GFR decrease > 50% x 12 h
Failure Increase SCr x3 UO < 0.3 ml/kg/h
GFR decrease 75% x24 h or
OR SCr ≥ 4mg/dl Anuria x12 h
Loss Complete loss of Complete loss of
function > 4 weeks function > 4 weeks
ESKD End stage kidney End stage kidney
disease > 3 months disease > 3 months
68
Table A2: AKIN classification of AKI [36]. Modified from RIFLE criteria.
Creatinine Criteria Urine Output Criteria
Stage 1 serum creatinine of ≥ 0.3 mg/dL ≤ 0.5 ml/kg/h for > 6 h
(≥ 26.4 umol/L) or increase to ≥150% - 200%
(1.5 - to - 2-fold) from baseline
Stage 2 Increase in SCr to > 200% - 300% <0.5 ml/kg/h for > 2h
(> 2 to 3-fold) from baseline
Stage 3 Increase in SCr to > 300% <0.3 ml/kg/h or anuria>12h
(> 3-fold) from baseline or SCr ≥4.0 mg/dL
≥354umol/L with an acute rise of at least
0.5 mg/dL (44 umol/L)
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APPENDIX B
LIBRARY DEVELOPMENT FOR MODEL INITIAL CONDITIONS
# −∗− coding: utf−8 −∗−
”””
Created on Sat Oct 21 23:58:14 2017
@author: Evan
”””
import numpy as np
import pylab as P
import pandas as pd
Continual Inf = 0.0958
Days = 20
”””
My Volumes at the end
”””
Vs f = []
Vrbc f = []
Ve f = []
Vi f = []
Cs f = []
Crbc f = []
Cxe f = []
Cxm f = []
CsW f = []
CrbcW f = []
CxW f = []
gfr v = np.linspace(0,1,1000)
for i in range(len(gfr v)):
def rhs(t ,y):
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Vs, Vrbc, Ve, Vi, Cs, Crbc, Cxe, Cxm, CsW, CrbcW, CxW = y
GFRs = gfr v[i]
kie = 5 / (1 + np.exp(3∗(Vi − 26)))
kei = kie∗26/11
Vtot = Vi+Ve+Vs+Vrbc
Vb = Vs + Vrbc
kGFR = 44/(3∗8)∗GFRs
kc = 0.0094 + (0.833 − 0.0094)/(1+np.exp(−2.25∗(Vtot − (43.1892))))∗GFRs
S = .1/3 / (1+np.exp(−6∗(Vtot − 38.2)))
ksr = .006
krs = 3/2∗ksr
kse = 44/3 + (1/(1+ 1∗np.exp(−6∗(Vb − 7))))∗2.1429∗Ve
kes = 4
dVs = krs∗Vrbc − ksr∗Vs + kes∗Ve − kse∗Vs − kc − S + Continual Inf
dVrbc = ksr∗Vs − krs∗Vrbc
dVe = −(kei+kes)∗Ve + kie ∗ Vi + kse∗Vs
dVi = kei∗Ve − kie∗Vi
G = 30 + (52.9557 − 30)∗GFRs/(0.6397 + GFRs)
Vx = Vi + Ve
Vxe = 0.6∗Vx
Vxm = 0.4∗Vx
dVxm = 0.4∗(dVi + dVe)
dVxe = 0.6∗(dVi + dVe)
R = 3.12∗(0.7∗Vrbc/((0.7/0.93)∗(Vrbc/(Vs−Vrbc))+1))
Q = 5
dCxm = G/Vxm + Q∗(Cs−Cxm)/Vxm − Cxm/Vxm∗dVxm
dCxe = Q∗(Cs−Cxe)/Vxe − Cxe/Vxe∗dVxe
dCs = Q/Vs∗(Cxm − Cs) + Q/Vs∗(Cxe − Cs) + R/Vs∗(Crbc−Cs) − (kGFR)∗Cs −
Cs/Vs∗dVs
dCrbc = R∗(Cs−Crbc)/Vrbc − Crbc/Vrbc∗dVrbc
######## COMPARATIVE MODEL
R0 = 1.743#454
kGFR W = 44/(3∗8)∗gfr v[i]
dCxW = 5/(11+26)∗(CsW−CxW)
dCsW = 5/3∗(CxW−CsW) + R0/3∗(CrbcW−CsW) + 44/3 −kGFR W∗CsW
dCrbcW = R0∗(CsW−CrbcW)/2
return P.array([dVs, dVrbc, dVe, dVi, dCs, dCrbc, dCxe, dCxm, dCsW, dCrbcW,
dCxW])
Cs0 = 8
Crbc0 = Cs0
Cxe0 = Cs0
Cxm0 = 44/5 + Cxe0
y0=np.array([3, 2, 11, 26, Cs0, Crbc0, Cxe0, Cxm0, Cs0, Crbc0, Cxe0])
t0=0
model = Explicit Problem(rhs, y0, t0)
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model.name = ’Linear Test ODE’
sim = CVode(model)
t , y = sim.simulate(Days∗24)
Vs l = y[−1,0]
Vrbc l = y[−1,1]
Ve l = y[−1,2]
Vi l = y[−1,3]
Cs l = y[−1,4]
Crbc l = y[−1,5]
Cxe l = y[−1,6]
Cxm l = y[−1,7]
CsW l = y[−1,8]
CrbcW l = y[−1,9]
CxW l = y[−1,10]
Vs f.append(Vs l)
Vrbc f.append(Vrbc l)
Ve f.append(Ve l)
Vi f .append(Vi l)
Cs f.append(Cs l)
Crbc f.append(Crbc l)
Cxe f.append(Cxe l)
Cxm f.append(Cxm l)
CsW f.append(CsW l)
CrbcW f.append(CrbcW l)
CxW f.append(CxW l)
df = pd.DataFrame({’GFRs’:gfr v,’Vs’:Vs f,’Vrbc’:Vrbc f,’Ve’:Ve f, ’Vi’ : Vi f , ’Cs’:Cs f, ’Crbc’:
Crbc f, ’Cxe’:Cxe f, ’Cxm’:Cxm f})
dfW = pd.DataFrame({’GFRsW’:gfr v,’CsW’:CsW f,’CrbcW’:CrbcW f,’CxW’:CxW f})
df = df.set index( ’Cs’)
dfW = dfW.set index(’CsW’)
df . to csv( ’CKD Conditions Library edr.csv’)
dfW.to csv(’CKD Static Conditions edr.csv’)
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APPENDIX C
THEORETICAL MODEL SIMULATION CODE
# −∗− coding: utf−8 −∗−
”””
Created on Tue Jan 3 21:05:23 2017
@author: Evan
”””
import pandas as pd
import numpy as np
import pylab as P
import matplotlib.pyplot as plt
lib = pd.read csv(’CKD Conditions Library edr.csv’)
lib = lib. set index( ’Cs’)
libW = pd.read csv(’CKD Static Conditions edr.csv’)
libW = libW.set index(’CsW’)
Cs0 = 8 # Creatinine Baselines: 8, 12, 21, 38, 8 = 100%, 12 = 66.7%, 21 = 38.1%, 38 =
21.0%
Injury = 0 #0,0.35,0.7,1.0
lib index = lib.index. get loc (Cs0, method = ’nearest’)
lib indexW=libW.index.get loc(Cs0, method = ’nearest’)
cmin = 6 # Building windows for SCr Concentration Viewing
cmax = 18 # None = 30 ; Stage2 = 40 ; Stage3 = 60 ; Stage4 = 90
Inf =0.3125
Days = 3
d tot = 8
def rhs(t ,y):
73
Vs, Vrbc, Ve, Vi, Cs, Crbc, Cxe, Cxm, CsW, CrbcW, CxW = y
GFR s = lib.iloc[ lib index ][ ’GFRs’]# − Injury∗lib.iloc[lib index ][’ GFRs’]∗(t>80) #−
.7#∗(t>80)#∗(t>48)#/(1+np.exp(−.2∗(t − 48))) #− .68∗(t>48)#∗(t<96)
G = 30 + (52.9557 − 30)∗(GFR s)/(0.6397 + GFR s)#44
kie = 5 / (1 + np.exp(3∗(Vi − 26)))
kei = kie∗26/11
Vtot = Vi+Ve+Vs+Vrbc
Vb = Vs + Vrbc
kGFR = 44/(3∗8)∗GFR s
kc = 0.0094 + GFR s∗(0.833 − 0.0094)/(1+np.exp(−2.25∗(Vtot − (43.1892))))
S = .1/3 / (1+np.exp(−6∗(Vtot − 38.2)))
ksr = .006
krs = 3/2∗ksr
kse = 44/3 + (1/(1+ 1∗np.exp(−6∗(Vb − 7))))∗2.1429∗Ve
kes = 4
dVs = krs∗Vrbc − ksr∗Vs + kes∗Ve − kse∗Vs − kc − S#+ 0.0958∗(t<24) +0.5∗(t>72)∗(t
<96) + 0.0958∗(t>=96)#.5∗(t>48)∗(t<60) + .1166∗(t>60)# − S #+ .11923# +
.5/(1+np.exp(−3∗(t − 48))) − .5/(1+np.exp(−3∗(t − 60))) + .1166/(1+np.exp(−3∗(t
− 60)))# .5∗(t>48)#∗(t<60) + .1166∗(t>60)
dVrbc = ksr∗Vs − krs∗Vrbc
dVe = −(kei+kes)∗Ve + kie ∗ Vi + kse∗Vs
dVi = kei∗Ve − kie∗Vi
Vx = Vi + Ve
Vxe = 0.6∗Vx
Vxm = 0.4∗Vx
dVxm = 0.4∗(dVi + dVe)
dVxe = 0.6∗(dVi + dVe)
R = 3.12∗(0.7∗Vrbc/((0.7/0.93)∗(Vrbc/(Vs−Vrbc))+1))
Q = 5
dCxm = G/Vxm + Q∗(Cs−Cxm)/Vxm − Cxm/Vxm∗dVxm
dCxe = Q∗(Cs−Cxe)/Vxe − Cxe/Vxe∗dVxe
dCs = Q/Vs∗(Cxm − Cs) + Q/Vs∗(Cxe − Cs) + R/Vs∗(Crbc−Cs) − (kGFR)∗Cs − Cs/
Vs∗dVs
dCrbc = R∗(Cs−Crbc)/Vrbc − Crbc/Vrbc∗dVrbc
#Static Model
GFRsW = libW.iloc[lib indexW][’GFRsW’] − Injury∗libW.iloc[lib indexW][’GFRsW’]∗(t
>80)
R0 = 1.743
kGFR W = 44/(3∗8)∗GFRsW
dCxW = 5/(11+26)∗(CsW−CxW)
dCsW = 5/3∗(CxW−CsW) + R0/3∗(CrbcW−CsW) + 44/3 −kGFR W∗CsW
dCrbcW = R0∗(CsW−CrbcW)/2
return P.array([dVs, dVrbc, dVe, dVi, dCs, dCrbc, dCxe, dCxm, dCsW, dCrbcW, dCxW])
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Crbc0 = Cs0
Cxe0 = Cs0
Cxm0 = lib.iloc[ lib index ][ ’Cxm’]
y0=np.array([lib. iloc [ lib index ][ ’Vs’ ], lib . iloc [ lib index ][ ’Vrbc’ ], lib . iloc [ lib index ][ ’Ve’ ],
lib . iloc [ lib index ][ ’Vi’ ], Cs0, Crbc0, Cxe0, Cxm0, Cs0, libW.iloc[lib indexW][’CrbcW’],
libW.iloc[lib indexW][’CxW’]])
t0=0
from assimulo.problem import Explicit Problem
model = Explicit Problem(rhs, y0, t0)
model.name = ’Linear Test ODE’
from assimulo.solvers import CVode
sim = CVode(model)
tfinal = 28 − d tot∗2 + 2∗(d tot − 1)∗8/d tot + 24∗(Days − 1)
t , y = sim.simulate(2)
ymaster=[]
ymaster.append(y [:,:])
tmaster =[]
tmaster.append(t[:])
tspan = []
Drink = []
for i in range(Days):
for m in range(d tot):
if m < (d tot − 1):
Drink = [(2+ 2∗m∗8/d tot + 24∗i, 4 + 2∗m∗8/d tot + 24∗i )]
else:
Drink = [(2 + 2∗m∗8/d tot + 24∗i, 28 − d tot∗2 + 2∗m∗8/d tot + 24∗i)]
tspan.append(Drink)
tspan ar = sum(tspan,[])
for tspan in tspan ar:
y0 = [y[−1,0]+Inf, y[−1,1], y[−1,2], y[−1,3], y[−1,4]∗y[−1,0] / (y[−1,0]+Inf), y[−1,5], y
[−1,6], y[−1,7], y[−1,8], y[−1,9], y[−1,10]]
model = Explicit Problem(rhs, y0, tspan[0])
sim = CVode(model)
t ,y = sim.simulate(tspan[1])
ymaster.append(y [:,:])
tmaster.append(t[:])
y0 = y[−1,:]
model = Explicit Problem(rhs, y0, tspan[−1])
t ,y = sim.simulate( tfinal )
ymaster.append(y)
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tmaster.append(t)
ymaster = np.concatenate(ymaster, axis=0)
tmaster = np.concatenate(tmaster, axis=0)
”””
Graphs
”””
Vs = ymaster[:,0]
Vrbc = ymaster[:,1]
Ve = ymaster[:,2]
Vi = ymaster[:,3]
Cs = ymaster[:,4]
Crbc = ymaster[:,5]
Cxe = ymaster[:,6]
Cxm = ymaster[:,7]
CsW = ymaster[:,8]
CrbcW = ymaster[:,9]
CxW = ymaster[:,10]
Vb = Vs + Vrbc
Vtotal = Vs+Vrbc+Ve+Vi
”””
Volume
”””
tf = Days ∗ 24
P.subplot(4,1,1)
P.plot(tmaster,Vi, label=’$V i$’, linewidth = 2, color = ’magenta’)
P. title ( ’Volume Kinetics’)
P.legend()
P.ylim(25,27)
P.xlim(0,tf )
P.locator params(axis=’y’, nbins=2)
P.gca().xaxis. set major locator(P.NullLocator())
P.subplot(4,1,2)
P.plot(tmaster,Ve, label=’$V e$’, linewidth = 2, color = ’green’)
P.ylim(10,13)
P.xlim(0,tf )
P.locator params(axis=’y’, nbins=2)
P.gca().xaxis. set major locator(P.NullLocator())
P.legend()
P.subplot(4,1,3)
P.plot(tmaster,Vs, label=’$V s$’, linewidth = 2, color = ’blue’)
P.ylim(2,4)
P.xlim(0,tf )
P.locator params(axis=’y’, nbins=2)
P.gca().xaxis. set major locator(P.NullLocator())
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P.legend()
P.subplot(4,1,4)
P.plot(tmaster,Vrbc, label=’$V {rbc}$’, linewidth = 2, color = ’red’)
P.ylim(1,3)
P.xlim(0,tf )
P.xticks(P.arange(0,24∗(Days+1),24))
P.locator params(axis=’y’, nbins=2)
P.legend()
P.xlabel( ’time (h)’)
P.figure ()
P.ylabel( ’Volume (L)’)
P.xlabel( ’Time (h)’)
P.plot(tmaster,Vs, label=’$V s$’, linewidth = 2, color = ’blue’)
P.plot(tmaster,Vrbc, label=’$V {rbc}$’, linewidth = 2, color = ’red’)
P.plot(tmaster,Ve, label=’$V e$’, linewidth = 2, color = ’green’)
P.plot(tmaster,Vi, label=’$V i$’, linewidth = 2, color = ’magenta’)
P.ylim((0,30))
P.xlim((0, tf ))
P.grid()
P.legend(loc = 1, bbox to anchor=(1.27, 0.8))
vlines = [24,48,72,96, 120, 144,168,192,216,240]
for xpos in vlines :
P.axvline(x = xpos, color = ’black’)
P.xticks(P.arange(0,24∗(Days+1),24))
”””
Concentration
”””
P.figure ()
P.ylabel( ’Concentration (mg/L)’)
P.xlabel( ’Time (h)’)
P.plot(tmaster,Cs, label=’Cs(t)’, linewidth = 2, color = ’blue’)
P.plot(tmaster,Crbc, label=’Crbc(t)’, linewidth = 2, color = ’red’)
P.plot(tmaster,Cxm, label=’Cxm(t)’, linewidth = 2, color = ’green’)
P.plot(tmaster,Cxe, label=’Cxe(t)’, linewidth = 2, color = ’magenta’)
#P.plot(tmaster,CsW, label=’SCr (Static Volume and Generation)’, linewidth = 2, color = ’
black’, linestyle = ’−−’)
P.ylim((cmin,cmax))
P.xlim((0, tf ))
#P.legend(loc=2)
P.legend(loc = 2, bbox to anchor=(0, .75), ncol=1)
ylines = [Cs0, np.interp(Days∗24, tmaster, Cs)]
for xpos in vlines :
P.axvline(x = xpos, color = ’black’)
77
P.xticks(P.arange(0,24∗(Days+1),24))
P.grid()
”””
Total Volume
”””
P.figure ()
P.ylabel( ’Total Volume (L)’)
P.xlabel( ’Time (h)’)
P.plot(tmaster,Vtotal, label=’Vtotal’, linewidth = 2, color = ’red’)
P.ylim((35,45))
P.xlim((0, tf ))
ytotlines = [38.22,40.74,42]
for xpos in ytotlines :
P.axhline(y = xpos, color = ’black’)
for xpos in vlines :
P.axvline(x = xpos, color = ’black’)
P.xticks(P.arange(0,24∗(Days+1),24))
”””
Blood/ Interstitial Volume
”””
P.figure ()
P.ylabel( ’Vb (L)’)
P.xlabel( ’Ve (L)’)
P.plot(Ve,Vb, linewidth = 2, color = ’blue’)
P.xlim(11,42)
P.ylim(5,8)
P.axvline(x = 11)
blines = [5,7]
for yspot in blines :
P.axhline(y = yspot)
”””
Extracting Information from Plots
”””
O = ’\033[33m’ # orange
P = ’\033[35m’ # purple
W = ’\033[0m’ # white (normal)
print(’Vs @ 120h = %s’%(np.interp(120, tmaster, Vs)))
print(’Vrbc @ 120h = %s’%(np.interp(120, tmaster, Vrbc)))
print(’Ve @ 120h = %s’%(np.interp(120, tmaster, Ve)))
print(’Vi @ 120h = %s’%(np.interp(120, tmaster, Vi)))
print(P+’Vtot @ 0h = %s’%(np.interp(0,tmaster,Vtotal)))
print(P+’Vtot @ 104h = %s’%(np.interp(104,tmaster,Vtotal)))
print(P+’SCr @ 120h = %s’%(np.interp(120, tmaster, Cs)))
print(O+’SCrW @ 120h = %s’%(np.interp(120, tmaster, CsW)))
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print(W+’SCr:SCrW Ratio @ 120h = %s’%(np.interp(120, tmaster, Cs)/np.interp(120, tmaster,
CsW)))
print(P+’GFRs @t=0h = %s’ %(lib.iloc[lib index][’GFRs’]))
print(P+’GFRs @t>80h = %s’%(lib.iloc[lib index][’GFRs’] − Injury∗lib.iloc[lib index][’GFRs’]))
print(O+’GFRsW @t=0h = %s’ %(libW.iloc[lib indexW][’GFRsW’]))
print(O+’GFRsW @t>80h = %s’%(libW.iloc[lib indexW][’GFRsW’] − Injury∗libW.iloc[
lib indexW][’GFRsW’]))
print(P+’Change in SCr from 80h to 104h = %s’%(np.interp(104, tmaster, Cs)−np.interp(80,
tmaster, Cs)))
print(O+’Change in SCrW from 80h to 104h = %s’%(np.interp(104, tmaster, CsW)−np.interp
(80, tmaster, CsW)))
if Injury == 0:
print(W+’%% difference in changes = N/A’)
else:
print(W+’%% difference in changes = %s’%((−(np.interp(104, tmaster, Cs)−np.interp(80,
tmaster, Cs)) + (np.interp(104, tmaster, CsW)−np.interp(80, tmaster, CsW)))/(np.
interp(104, tmaster, CsW)−np.interp(80, tmaster, CsW))∗100))
print(’ difference in changes = %s’%((np.interp(104, tmaster, Cs)−np.interp(80, tmaster, Cs))
− (np.interp(104, tmaster, CsW)−np.interp(80, tmaster, CsW))))
print(P+’Change in SCr from 72h to 96h = %s’%(np.interp(96, tmaster, Cs)−np.interp(72,
tmaster, Cs)))
print(O+’Change in SCrW from 72h to 96h = %s’%(np.interp(96, tmaster, CsW)−np.interp(72,
tmaster, CsW)))
if Injury == 0:
print(W+’%% difference in changes = N/A’)
else:
print(W+’%% difference in changes = %s’%(((np.interp(96, tmaster, CsW)−np.interp(72,
tmaster, CsW))−(np.interp(96, tmaster, Cs)−np.interp(72, tmaster, Cs)))/(np.interp(96,
tmaster, CsW)−np.interp(72, tmaster, CsW))∗100))
print(’ difference in changes = %s’%((np.interp(96, tmaster, Cs)−np.interp(72, tmaster, Cs)) −
(np.interp(96, tmaster, CsW)−np.interp(72, tmaster, CsW))))
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APPENDIX D
MODEL FITTING TO PATIENT DATA
# −∗− coding: utf−8 −∗−
”””
Created on Sat Aug 5 23:12:05 2017
@author: Evan
”””
import os
clear = lambda: os.system(’cls’)
import matplotlib.pyplot as plt
from pyomo.environ import ∗
import numpy as np
from pyomo.dae import ∗
import pandas as pd
PVIDs =
[34648440,34507970,33981050,34396040,34276822,32914196,33182922,33341773,33164780,32849855]
# Load the CSV’s
df all 1 = pd.read csv(’Patients Data SCr.csv’)
df all 2 = pd.read csv(’Patients Data FluidOUT.csv’)
df all 3 = pd.read csv(’Patients Data FluidIN.csv’)
lib = pd.read csv(’CKD Conditions Library edr.csv’)
lib = lib. set index( ’Cs’)
#Processing Per Patient
for NUMBER in PVIDs:
”””
PROCESSING DATA
”””
df1 = df all 1 .groupby(’PVID’).get group(NUMBER)
df2 = df all 2 .groupby(’PVID’).get group(NUMBER)
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df3 = df all 3 .groupby(’PVID’).get group(NUMBER)
df1[ ’Date’] = pd.to datetime(df1[’Date’]) # Convert string to datetime
object
starttime = df1. iloc [0][ ’Date’] # Get patient start time
elapsed = df1[’Date’] − starttime # Get time elapsed (pandas timedelta)
elapsed = elapsed/ np.timedelta64(1, ’h’) # Convert pandas timedelta into
hours (float)
df1[ ’ t ’ ] = elapsed
df1[ ’SCr’] = df1[’SCr mg/L’]
df1 = df1.set index( ’ t ’ )
df SCr = df1
df SCr.dropna(axis = 0, inplace= False)
df SCr[’ diff SCr ’ ] = df SCr[’SCr’]. diff ()
df SCr[’ diff SCr ’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
df SCr[’ diff SCr ’ ] = df SCr[’diff SCr ’ ]. shift (−1)
df SCr[’ diff SCr ’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
df SCr[’ diff t ’ ] = df SCr.index. to series () . diff ()
df SCr[’ diff t ’ ] = df SCr[’ diff t ’ ]. shift (−1)
df SCr[’ diff t ’ ]. replace( to replace = [’NaN’], value = 1, inplace = True)
df SCr[’dSCr’] = df SCr[’diff SCr ’ ]/df SCr[’ diff t ’ ]
df SCr[’MAx 24’] = df SCr[’dSCr’]∗24
df2[ ’Date’] = pd.to datetime(df2[’Date’]) # Convert string to datetime object
elapsed2 = df2[’Date’] − starttime #df2.iloc [0][’ Datetime’] #
Calculate time elapsed
elapsed2 = elapsed2/np.timedelta64(1, ’h’) # Convert time elapsed into
hours
df2[ ’ t ’ ] = elapsed2
df2 = df2.set index( ’ t ’ ) # Set time as index
df3[ ’Date’] = pd.to datetime(df3[’Date’]) # Convert string to datetime object
elapsed3 = df3[’Date’] − starttime #df2.iloc [0][’ Datetime’] #
Calculate time elapsed
elapsed3 = elapsed3/np.timedelta64(1, ’h’) # Convert time elapsed into
hours
df3[ ’ t ’ ] = elapsed3
df3 = df3.set index( ’ t ’ )
df1 = df1.loc [np.union1d(df1.index.values, df2.index.values) ] #df1 is used to give all time
points to the model
df1 = df1.loc [np.union1d(df1.index.values, df3.index.values) ] #so all time points from df1,
df2, and df3 are given to df1
df1[ ’PVID’].replace(to replace = [’NaN’], value = NUMBER, inplace = True)
df1[ ’SCr’ ]. interpolate (method=’index’, axis=0, limit=None, inplace=True, limit direction=’
forward’)
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df1[ ’SCr mg/L’].interpolate(method=’index’, axis=0, limit=None, inplace=True,
limit direction=’forward’)
df1 = df1.groupby(df1.index).mean()
Urineout = df2.groupby(’IODetail’).get group(’Urineout’)
Urineout = Urineout[Urineout[’Volume L’] != 0]
Urineout = Urineout.groupby(Urineout.index).agg(sum)
Urineout[’Urine Tot’] = Urineout[’Volume L’].cumsum()
df2 = df2.loc [np.union1d(df2.index.values, df1.index.values) ] # df2 time points may not
exist in df1. Rectify that.
df2 = df2.loc [np.union1d(df2.index.values, df3.index.values) ]
df2[ ’PVID’].replace(to replace = [’NaN’], value = NUMBER, inplace = True)
df2[ ’Volume L’].replace(to replace = [’NaN’], value = 0, inplace = True)
df2[ ’IODetail’ ]. fillna (value = ’VeLoss’, inplace = True)
VeLoss = df all 2 .groupby(’PVID’).get group(NUMBER)
VeLoss[’Date’] = pd.to datetime(VeLoss[’Date’]) # Convert string to datetime object
elapsed V = VeLoss[’Date’] − starttime #df2.iloc [0][’ Datetime’] #
Calculate time elapsed
elapsed V = elapsed V/np.timedelta64(1, ’h’) # Convert time elapsed
into hours
VeLoss[’t ’ ] = elapsed V
VeLoss = VeLoss.set index(’t’)
VeLoss[’PVID’].replace(to replace = [’NaN’], value = NUMBER, inplace = True)
VeLoss[’Volume L’].replace(to replace = [’NaN’], value = 0, inplace = True)
VeLoss[’IODetail’ ]. fillna (value = ’VeLoss’, inplace = True)
if len(Urineout[’Volume L’]) == len(VeLoss[’Volume L’]):
VeLoss[’Volume L’] = 0.0
else:
VeLoss = VeLoss.groupby(’IODetail’).get group(’VeLoss’)
VeLoss = VeLoss.groupby(VeLoss.index).agg(sum)
VeLoss[’vol tot ’ ] = VeLoss[’Volume L’].cumsum()
VeLoss[’ diff ’ ] = VeLoss[’vol tot ’ ]. diff ()
VeLoss[’ diff ’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
VeLoss[’ diff t ’ ] = VeLoss.index.to series () . diff ()
VeLoss[’ diff t ’ ]. replace( to replace = [’NaN’], value = 1, inplace = True)
VeLoss[’slope’ ] = VeLoss[’diff ’ ]/VeLoss[’ diff t ’ ]
VeLoss[’slope’ ] = VeLoss[’slope’ ]. shift (−1)
VeLoss[’slope’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
”””
BEGIN FLUID IN WORK
”””
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Data = []
Data.insert (0, {’PVID’ : NUMBER , ’Volume L’ : 0})
check 1 = ’IV’ in df3.Fluid In Method.values
if check 1 == 1:
IV = df3.groupby(’Fluid In Method’).get group(’IV’)
IV = IV.groupby(IV.index).agg(sum)
IV.dropna(axis = 0, inplace= False)
if IV.index[0] > 0:
IV = pd.concat([pd.DataFrame(Data), IV], ignore index=False)
IV[’vol tot ’ ] = IV[’Volume L’].cumsum()
IV[’ diff ’ ] = IV[’vol tot ’ ]. diff ()
IV[’ diff ’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
IV[’ diff t ’ ] = IV.index. to series () . diff ()
IV[’ diff t ’ ]. replace( to replace = [’NaN’], value = 1, inplace = True)
IV[’slope’ ] = IV[’ diff ’ ]/IV[’ diff t ’ ]
IV[’slope’ ] = IV[’slope’ ]. shift (−1)
IV[’slope’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
check 2 = ’Oral Intake’ in df3.Fluid In Method.values
if check 2 == 1:
Oral In = df3.groupby(’Fluid In Method’).get group(’Oral Intake’)
Oral In = Oral In.groupby(Oral In.index).agg(sum)
Oral In.dropna(axis = 0, inplace= False)
if Oral In.index[0] > 0:
Oral In = pd.concat([pd.DataFrame(Data), Oral In], ignore index=False)
Oral In[ ’vol tot ’ ] = Oral In[’Volume L’].cumsum()
Oral In[ ’ diff ’ ] = Oral In[’vol tot ’ ]. diff ()
Oral In[ ’ diff ’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
Oral In[ ’ diff t ’ ] = Oral In.index. to series () . diff ()
Oral In[ ’ diff t ’ ]. replace( to replace = [’NaN’], value = 1, inplace = True)
Oral In[ ’ slope’ ] = Oral In[’ diff ’ ]/Oral In[ ’ diff t ’ ]
Oral In[ ’ slope’ ] = Oral In[’slope’ ]. shift (−1)
Oral In[ ’ slope’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
check 3 = ’Continuous Infusions’ in df3.Fluid In Method.values
if check 3 == 1:
Cont Inf = df3.groupby(’Fluid In Method’).get group(’Continuous Infusions’)
Cont Inf = Cont Inf.groupby(Cont Inf.index).agg(sum)
Cont Inf.dropna(axis = 0, inplace= False)
if Cont Inf.index[0] > 0:
Cont Inf = pd.concat([pd.DataFrame(Data), Cont Inf], ignore index=False)
Cont Inf[ ’vol tot ’ ] = Cont Inf[’Volume L’].cumsum()
Cont Inf[ ’ diff ’ ] = Cont Inf[’vol tot ’ ]. diff ()
Cont Inf[ ’ diff ’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
Cont Inf[ ’ diff t ’ ] = Cont Inf.index. to series () . diff ()
Cont Inf[ ’ diff t ’ ]. replace( to replace = [’NaN’], value = 1, inplace = True)
Cont Inf[ ’ slope’ ] = Cont Inf[’ diff ’ ]/Cont Inf[ ’ diff t ’ ]
83
Cont Inf[ ’ slope’ ] = Cont Inf[’slope’ ]. shift (−1)
Cont Inf[ ’ slope’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
check 4 = ’Blood Products/Colloids’ in df3.Fluid In Method.values
if check 4 == 1:
B prod col = df3.groupby(’Fluid In Method’).get group(’Blood Products/Colloids’)
B prod col = B prod col.groupby(B prod col.index).agg(sum)
B prod col.dropna(axis = 0, inplace= False)
if B prod col.index[0] > 0:
B prod col = pd.concat([pd.DataFrame(Data), B prod col], ignore index=False)
B prod col[’vol tot ’ ] = B prod col[’Volume L’].cumsum()
B prod col[’ diff ’ ] = B prod col[’vol tot ’ ]. diff ()
B prod col[’ diff ’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
B prod col[’ diff t ’ ] = B prod col.index. to series () . diff ()
B prod col[’ diff t ’ ]. replace( to replace = [’NaN’], value = 1, inplace = True)
B prod col[’ slope’ ] = B prod col[’ diff ’ ]/B prod col[’ diff t ’ ]
B prod col[’ slope’ ] = B prod col[’slope’ ]. shift (−1)
B prod col[’ slope’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
check 5 = ’Operating Room Intake’ in df3.Fluid In Method.values
if check 5 == 1:
Oper In = df3.groupby(’Fluid In Method’).get group(’Operating Room Intake’)
Oper In = Oper In.groupby(Oper In.index).agg(sum)
Oper In.dropna(axis = 0, inplace= False)
if Oper In.index[0] > 0:
Oper In = pd.concat([pd.DataFrame(Data), Oper In], ignore index=False)
Oper In[’vol tot ’ ] = Oper In[’Volume L’].cumsum()
Oper In[’ diff ’ ] = Oper In[’vol tot ’ ]. diff ()
Oper In[’ diff ’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
Oper In[’ diff t ’ ] = Oper In.index.to series () . diff ()
Oper In[’ diff t ’ ]. replace( to replace = [’NaN’], value = 1, inplace = True)
Oper In[’slope’ ] = Oper In[’diff ’ ]/Oper In[’ diff t ’ ]
Oper In[’slope’ ] = Oper In[’slope’ ]. shift (−1)
Oper In[’slope’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
check 6 = ’Feeding Tube Intake’ in df3.Fluid In Method.values
if check 6 == 1:
Feed In = df3.groupby(’Fluid In Method’).get group(’Feeding Tube Intake’)
Feed In = Feed In.groupby(Feed In.index).agg(sum)
Feed In.dropna(axis = 0, inplace= False)
if Feed In.index[0] > 0:
Feed In = pd.concat([pd.DataFrame(Data), Feed In], ignore index=False)
Feed In[ ’vol tot ’ ] = Feed In[’Volume L’].cumsum()
Feed In[ ’ diff ’ ] = Feed In[’vol tot ’ ]. diff ()
Feed In[ ’ diff ’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
Feed In[ ’ diff t ’ ] = Feed In.index. to series () . diff ()
Feed In[ ’ slope’ ] = Feed In[’ diff ’ ]/Feed In[ ’ diff t ’ ]
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Feed In[ ’ slope’ ] = Feed In[’slope’ ]. shift (−1)
Feed In[ ’ slope’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
check 7 = ’Enteral Intake’ in df3.Fluid In Method.values
if check 7 == 1:
Enteral In = df3.groupby(’Fluid In Method’).get group(’Enteral Intake’)
Enteral In = Enteral In.groupby(Enteral In.index).agg(sum)
Enteral In.dropna(axis = 0, inplace= False)
if Enteral In.index[0] > 0:
Enteral In = pd.concat([pd.DataFrame(Data), Enteral In], ignore index=False)
Enteral In[ ’vol tot ’ ] = Enteral In[’Volume L’].cumsum()
Enteral In[ ’ diff ’ ] = Enteral In[’vol tot ’ ]. diff ()
Enteral In[ ’ diff ’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
Enteral In[ ’ diff t ’ ] = Enteral In.index. to series () . diff ()
Enteral In[ ’ diff t ’ ]. replace( to replace = [’NaN’], value = 1, inplace = True)
Enteral In[ ’ slope’ ] = Enteral In[’ diff ’ ]/Enteral In[ ’ diff t ’ ]
Enteral In[ ’ slope’ ] = Enteral In[’slope’ ]. shift (−1)
Enteral In[ ’ slope’ ]. replace( to replace = [’NaN’], value = 0, inplace = True)
”””
END FLUID IN WORK
”””
# Something used for the Constraints, Fluid Input, VeLoss, and Obj Function
def return pairs(times):
return [(times[i ], times[ i+1]) for ( i ,time) in enumerate(times[:−1])]
# Initialize Model
model = ConcreteModel()
# Define timepoints
model.t = ContinuousSet(initialize = df1.index.values)
”””
FLUID IN SYSTEM FOR PYOMO
”””
if check 1 == 1:
def IV in(t) :
for i , t tuple in enumerate(return pairs(IV.index.values)):
t lb , t ub = t tuple
if t >= t lb and t <= t ub:
return IV.slope.iloc [ i ]
return 0
else:
def IV in(t) :
return 0
if check 2 == 1:
def Oral in(t) :
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for i , t tuple in enumerate(return pairs(Oral In.index.values)):
t lb , t ub = t tuple
if t >= t lb and t <= t ub:
return Oral In.slope. iloc [ i ]
return 0
else:
def Oral in(t) :
return 0
if check 3 == 1:
def Cont in(t):
for i , t tuple in enumerate(return pairs(Cont Inf.index.values)):
t lb , t ub = t tuple
if t >= t lb and t <= t ub:
return Cont Inf.slope.iloc [ i ]
return 0
else:
def Cont in(t):
return 0
if check 4 == 1:
def Blood in(t):
for i , t tuple in enumerate(return pairs(B prod col.index.values)):
t lb , t ub = t tuple
if t >= t lb and t <= t ub:
return B prod col.slope.iloc [ i ]
return 0
else:
def Blood in(t):
return 0
if check 5 == 1:
def Oper in(t):
for i , t tuple in enumerate(return pairs(Oper In.index.values)):
t lb , t ub = t tuple
if t >= t lb and t <= t ub:
return Oper In.slope.iloc[ i ]
return 0
else:
def Oper in(t):
return 0
if check 6 == 1:
def Feed in(t) :
for i , t tuple in enumerate(return pairs(Feed In.index.values)):
t lb , t ub = t tuple
if t >= t lb and t <= t ub:
return Feed In.slope.iloc [ i ]
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return 0
else:
def Feed in(t) :
return 0
if check 7 == 1:
def Enteral in(t) :
for i , t tuple in enumerate(return pairs(Enteral In.index.values)):
t lb , t ub = t tuple
if t >= t lb and t <= t ub:
return Enteral In.slope. iloc [ i ]
return 0
else:
def Enteral in(t) :
return 0
def Ve out(t):
for j , t tuple in enumerate(return pairs(VeLoss.index.values)):
t lb , t ub = t tuple
if t>= t lb and t<= t ub:
return VeLoss.slope.iloc[ j ]
return 0
”””
DEFINING STATE VARIABLES
”””
model.Vs = Var(model.t, within=NonNegativeReals, initialize = 3)
model.Vrbc = Var(model.t, within=NonNegativeReals, initialize = 2)
model.Ve = Var(model.t, within=NonNegativeReals, initialize = 11)
model.Vi = Var(model.t, within=NonNegativeReals, initialize = 26)
model.B tot = Var(model.t, within =NonNegativeReals, initialize = 0)
model.U tot = Var(model.t, within =NonNegativeReals, initialize = 0)
model.Cs = Var(model.t, within=NonNegativeReals, initialize = 8)
model.Crbc = Var(model.t, within=NonNegativeReals, initialize = 8)
model.Cxe = Var(model.t, within=NonNegativeReals, initialize = 8)
model.Cxm = Var(model.t, within=NonNegativeReals, initialize = 44/10+model.Cs[0])
model.FI tot = Var(model.t, within=NonNegativeReals, initialize = 0)
model.FO tot = Var(model.t, within=NonNegativeReals, initialize = 0)
”””
Define Parameter GFR s
”””
model.GFR s = Var(model.t, initialize = 1, bounds = (0,8/(df1.loc[df1.index [0], ’SCr’])))
”””
Defining derivative variables
”””
model.dVs = DerivativeVar(model.Vs, wrt=model.t)
model.dVrbc = DerivativeVar(model.Vrbc, wrt=model.t)
model.dVe = DerivativeVar(model.Ve, wrt=model.t)
model.dVi = DerivativeVar(model.Vi, wrt=model.t)
87
model.dCs = DerivativeVar(model.Cs, wrt=model.t)
model.dCrbc = DerivativeVar(model.Crbc, wrt=model.t)
model.dCxe = DerivativeVar(model.Cxe, wrt=model.t)
model.dCxm = DerivativeVar(model.Cxm, wrt=model.t)
model.dB tot = DerivativeVar(model.B tot, wrt = model.t)
model.dFI tot = DerivativeVar(model.FI tot, wrt = model.t)
model.dFO tot = DerivativeVar(model.FO tot, wrt = model.t)
”””
DEFINE INITIAL CONDITIONS
”””
Cs0 = df1.loc[df1.index [0], ’SCr’]
lib index = lib.index. get loc (Cs0, method = ’nearest’)
def init conditions (model):
yield model.Vs[0] == lib.iloc [ lib index ][ ’Vs’] # We make the Fluid In and the Fluid
Out in the data at t = 0 to be already accounted for in the model
yield model.Vrbc[0] == lib.iloc [ lib index ][ ’Vrbc’]
yield model.Ve[0] == lib.iloc [ lib index ][ ’Ve’]
yield model.Vi[0] == lib.iloc [ lib index ][ ’Vi’ ]
yield model.Cs[0] == Cs0
yield model.Crbc[0] == Cs0
yield model.Cxe[0] == Cs0
yield model.Cxm[0] == lib.iloc [ lib index ][ ’Cxm’]
yield model.B tot[0] == Urineout.loc[Urineout.index[0],’Urine Tot’]
yield model.FO tot[0] == VeLoss.loc[VeLoss.index[0], ’vol tot ’ ]
model. init conditions = ConstraintList(rule= init conditions)
”””
Begin Constraints
”””
def creat constraintA(model,t):
return model.Crbc[t] − model.Cs[t] <= 15
model.creat constraintA = Constraint(model.t, rule = creat constraintA)
def creat constraintB(model,t):
return −15 <= model.Crbc[t] − model.Cs[t]
model.creat constraintB = Constraint(model.t, rule = creat constraintB)
#Limiting GFR s
def GFRs Group lb(t):
for k, t tuple in enumerate(return pairs(df SCr.index.values)):
t lb , t ub = t tuple
if t >= t lb and t <= t ub:
return t lb
return 0
def GFRs Group ub(t):
for k, t tuple in enumerate(return pairs(df SCr.index.values)):
t lb , t ub = t tuple
if t >= t lb and t <= t ub:
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return t ub
return 0
def GFRs Constraint 1(model,t):
if t >= GFRs Group lb(t) and t < GFRs Group ub(t):
return model.GFR s[t] == model.GFR s[GFRs Group lb(t)]
else:
return Constraint.Skip
model.GFRs Constraint 1 = Constraint(model.t, rule = GFRs Constraint 1)
def GFRs Constraint 2(model,t):
return abs(model.GFR s[GFRs Group lb(t)] − model.GFR s[GFRs Group ub(t)]) <=
0.5
model.GFRs Constraint 2 = Constraint(model.t, rule = GFRs Constraint 2)
”””
REGULATING kc
”””
model.kc max = Var(initialize=0.833, bounds=(0.6,1.2))
model.kc slope = Var( initialize =−2.25, bounds=(−3,−1.5))
model.kc vol = Var( initialize = 38, bounds = (25.1892, 55.1892))
model.kc min = Var(initialize = 0.0094, bounds = (0.001,0.02))
model.kc = Var(model.t, within=NonNegativeReals)
def kc constrA(model,t):
Vtot = model.Vi[t]+model.Ve[t]+model.Vs[t]+model.Vrbc[t]
return model.kc[t] == model.kc min + model.GFR s[t]∗(model.kc max)/(1+exp(model.
kc slope∗(Vtot − (model.kc vol))))
model.kc constrA = Constraint(model.t, rule= kc constrA)
model.VeLoss = Var(model.t, within=NonNegativeReals)
def set FluidOut data(model,t):
if t in VeLoss.index.values:
return model.VeLoss[t] == VeLoss.loc[t, ’Volume L’]
else:
return model.VeLoss[t] == 0
model.set FluidOut data = Constraint(model.t, rule= set FluidOut data)
”””
Bladder, Fluid In, & Ve Out
”””
def B tot eq(model,t):
return model.dB tot[t] == model.kc[t]
model.B tot eq = Constraint(model.t, rule= B tot eq)
def dFI tot Constr(model,t):
return model.dFI tot[t] >= 0
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model.dFI tot Constr = Constraint(model.t, rule= dFI tot Constr)
def dFO tot ConstrA(model,t):
return model.dFO tot[t] >= 0
model.dFO tot ConstrA = Constraint(model.t, rule= dFO tot ConstrA)
def dFO tot ConstrB(model,t):
if t > VeLoss.index[−1]:
return model.dFO tot[t] == 0
else:
return model.dFO tot[t] >= 0
model.dFO tot ConstrB = Constraint(model.t, rule= dFO tot ConstrB)
”””
Volume Compartments
”””
def Vs eq(model,t): # Fluid is infused into this compartment (L/h)
ksr = 0.006
krs = 3/2∗ksr
Vb = model.Vs[t] + model.Vrbc[t]
kes = 4
kse = 11/3∗kes + (1/(1+ 1∗exp(−6∗(Vb − 7))))∗2.1429∗model.Ve[t]
Vtot = model.Vi[t]+model.Ve[t]+model.Vs[t]+model.Vrbc[t]
S = 0.1/3 / (1+exp(−6∗(Vtot − 38.2)))
return model.dVs[t] == krs∗model.Vrbc[t] − ksr∗model.Vs[t] + kes∗model.Ve[t] − kse∗
model.Vs[t] \
+ IV in(t) + Oral in(t) + Cont in(t) + Blood in(t) + Oper in(t)
+ Feed in(t) \
+ Enteral in(t) − model.kc[t] − S
model.Vs eq = Constraint(model.t, rule= Vs eq)
def Vrbc eq(model,t):
ksr = 0.006
krs = 3/2∗ksr
return model.dVrbc[t] == ksr∗model.Vs[t] − krs∗model.Vrbc[t]
model.Vrbc eq = Constraint(model.t, rule= Vrbc eq)
def Ve eq(model,t):
kie = 5 / (1 + exp(3∗(model.Vi[t] − 26)))
kei = kie∗26/11
Vb = model.Vs[t] + model.Vrbc[t]
kes = 4
kse = 11/3∗kes + (1/(1+ 1∗exp(−6∗(Vb − 7))))∗2.1429∗model.Ve[t]
return model.dVe[t] == kie ∗ model.Vi[t] + kse∗model.Vs[t] − kei∗model.Ve[t] − 4∗
model.Ve[t] − Ve out(t)
model.Ve eq = Constraint(model.t, rule= Ve eq)
def Vi eq(model,t):
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kie = 5 / (1 + exp(3∗(model.Vi[t] − 26)))
kei = kie∗26/11
return model.dVi[t] == kei∗model.Ve[t] − kie∗model.Vi[t]
model.Vi eq = Constraint(model.t, rule= Vi eq)
”””
Creatinine Concentration Compartments
”””
def Cs eq(model,t):
R = 3.12∗(0.7∗model.Vrbc[t]/((0.7/0.93)∗(model.Vrbc[t]/(model.Vs[t]−model.Vrbc[t]))
+1))
kGFR = 44/(3∗8)∗model.GFR s[t] ################## Operates off of
initial conditions of Vs and Cs
return model.dCs[t] == 5∗(model.Cxm[t]+model.Cxe[t]−2∗model.Cs[t])/model.Vs[t] +
R(model.Crbc[t]−model.Cs[t])/model.Vs[t] − kGFR∗model.Cs[t] − model.Cs[t]/
model.Vs[t]∗model.dVs[t]
model.Cs eq = Constraint(model.t, rule= Cs eq)
def Crbc eq(model,t):
R = 3.12∗(0.7∗model.Vrbc[t]/((0.7/0.93)∗(model.Vrbc[t]/(model.Vs[t]−model.Vrbc[t]))
+1))
return model.dCrbc[t] == R∗(model.Cs[t]−model.Crbc[t])/model.Vrbc[t] − model.Crbc
[t]/model.Vrbc[t]∗model.dVrbc[t]
model.Crbc eq = Constraint(model.t, rule= Crbc eq)
def Cxe eq(model,t):
Vxe = 0.6∗(model.Vi[t] + model.Ve[t])
dVxe = 0.6∗(model.dVi[t] + model.dVe[t])
Q = 5
return model.dCxe[t] == Q/Vxe∗(model.Cs[t]−model.Cxe[t]) − model.Cxe[t]/Vxe∗
dVxe
model.Cxe eq = Constraint(model.t, rule= Cxe eq)
”””
Creatinine Generation
”””
def Cxm eq(model,t):
Vxm = 0.4∗(model.Vi[t] + model.Ve[t])
dVxm = 0.4∗(model.dVi[t] + model.dVe[t])
G = 30 + (52.9557 − 30)∗model.GFR s[t]/(0.6397 + model.GFR s[t]) #model.G min +
(model.G max)∗(model.GFR s[t])/(model.k G + model.GFR s[t])
Q = 5
return model.dCxm[t] == G/Vxm + Q∗(model.Cs[t] − model.Cxm[t])/Vxm − model.
Cxm[t]/Vxm∗dVxm
model.Cxm eq = Constraint(model.t, rule= Cxm eq)
”””
Define Objective Function
”””
time = return pairs(np.array(model.t))
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time 2 = Urineout.index.values
time 3 = df SCr.index.values
def objectivefunc(model):
return sum(50∗[((model.GFR s[time[n][1]]−model.GFR s[time[n][0]])/(time[n][1]−time[n
][0]))∗∗2 for n in range(0,len(df1.index.values[1:]))]) \
+ sum(1∗[((model.kc[time[p][1]] − model.kc[time[p ][0]]) /(time[p ][0] − time[p ][1]) )
∗∗2 for p in range(0,len(df1.index.values [1:]) ) ]) \
+ sum(1100∗[(model.B tot[time 2[z]] − Urineout.loc[time 2[z], ’Urine Tot’])∗∗2 for
z in range(len(time 2))]) \
+ sum(700∗[(df SCr.loc[time 3[y], ’SCr’] − model.Cs[time 3[y]])∗∗2 for y in range(
len(df SCr.index.values))]) \
+ sum(1∗[((model.Cs[time[w−1][1]]−model.Cs[time[w−1][0]])/(model.t[w+1] −
model.t[w]))∗∗2 for w in range(1,len(df1.index.values[1:]))])
model.objective = Objective(rule=objectivefunc)
”””
SOLVING
”””
# Solver options
NFE = len(model.t)∗1
MaxIter = 10000
TOL = 1e−6
## Boilerplate code to solve −− converts ODEs into algebraic equations
discretizer =TransformationFactory(”dae.finite difference”) #discretizes the entire model
discretizer .apply to(model,nfe=NFE,wrt=model.t,scheme=”BACKWARD”) # discretizes
the entire model
# solve the problem
opt = SolverFactory(’ipopt’)
opt.options[ ’ linear solver ’ ] = ”ma97”
opt.options[ ’ tol ’ ] = TOL
opt.options[ ’max iter’ ] = MaxIter
”””
RESULTS
”””
results = opt.solve(model, keepfiles =False, tee=True)
model.solutions.load from(results )
print(results . solver .termination condition)
W = ’\033[0m’ # white (normal)
R = ’\033[31m’ # red
G = ’\033[32m’ # green
O = ’\033[33m’ # orange
B = ’\033[34m’ # blue
P = ’\033[35m’ # purple
print(B+’Patient %s’ %(NUMBER)+W)
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gfrs = np.array([model.GFR s[t]() for t in df1.index.values ])
Cs = np.array([model.Cs[t]() for t in df1.index.values ])
Crbc = np.array([model.Crbc[t]() for t in df1.index.values ])
Cxe = np.array([model.Cxe[t]() for t in df1.index.values ])
Cxm = np.array([model.Cxm[t]() for t in df1.index.values])
Vi = np.array([model.Vi[t]() for t in df1.index.values ])
Vs = np.array([model.Vs[t]() for t in df1.index.values ])
Vrbc = np.array([model.Vrbc[t]() for t in df1.index.values ])
Ve = np.array([model.Ve[t]() for t in df1.index.values ])
kc = np.array([model.kc[t ]() for t in df1.index.values ])
B tot = np.array([model.B tot[t]() for t in df1.index.values ])
FI tot = np.array([model.FI tot[t ]() for t in df1.index.values ])
FO tot = np.array([model.FO tot[t]() for t in df1.index.values ])
”””
Model Optimized Parameters
”””
kc vol = model.kc vol()
kc max = model.kc max()
kc slope = model.kc slope()
kc min = model.kc min()
np.savez(”Final Results edr %d” %(NUMBER), gfrs, Cs, Crbc, Cxe, Cxm, Vi, Vs, Vrbc,Ve,
kc, B tot, kc min, kc max, kc slope, kc vol)
clear ()
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APPENDIX E
THEORETICAL PATIENTS
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Figure E1: Theoretical patients (5-8) resulting volumes when baseline SCr is 12mgL, which
will not allow a return to 100% kidney function and nominal kc. Black, horizontal lines
represent 100% hydration, minor dehyrdation, and severe dehydration in descending order.
Initial volume distribution set by referencing built library for initial conditions to give equi-
librium at t=0h. Patient number is given in the upper, right-hand corner of each subplot.
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Figure E2: Theoretical patients SCr over the course of six days (144h). Baseline SCr is
12mgL-1 (Stage 2 CKD). Patient number is given in the upper, right-hand corner of each
subplot.
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Figure E3: Theoretical patients (9-12) resulting volumes when baseline SCr is 21mgL, which
will not allow a return to 100% kidney function and nominal kc. Black, horizontal lines
represent 100% hydration, minor dehyrdation, and severe dehydration in descending order.
Initial volume distribution set by referencing built library for initial conditions to give equi-
librium at t=0h. Patient number is given in the upper, right-hand corner of each subplot.
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Figure E4: Theoretical patients SCr over the course of six days (144h). Baseline SCr is
21mgL-1 (Stage 3 CKD). Patient number is given in the upper, right-hand corner of each
subplot.
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